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Feasibility and Acceptability of Using Mobile Health Apps in Underserved
Patients with Diabetes
Abstract
Introduction. Diabetes mellitus is a condition with a growing morbidity and mortality burden. An estimated
30 million adults currently live with diabetes, with each individual spending over $9500 annually on
medical care. The successful management of diabetes is a lifelong endeavor. This involves balancing a
variety of factors including diet, medications, and glucose monitoring. It has been well established that
successful control of diabetes depends largely upon patients’ daily lifestyle habits and activities. Not all
patients, however, have the resources necessary for effective diabetes management. Health disparities
lead to a higher rate of diabetes development in minority and poor populations. Since underserved
patients have limited access to traditional healthcare avenues, providers should explore other means, like
mobile health (mHealth), to help such patients. The rapid adoption of smartphones within the last decade
has allowed an opportunity for patients to use mHealth and smartphone applications (apps) as a lowcost way to get health information and services. mHealth has the potential to address such disparities in
access to health care. Little is known about the effectiveness of using apps to help underserved patients
with their diabetes management. Assessing these patients’ current self-management practices and their
interest in using smartphone apps for their diabetes management is the first step in determining how
mHealth may benefit this patient population.
Purpose. The purpose of this study was to assess how underserved patients with limited access to
primary care physicians handled their diabetes on their own at home, to determine what challenges they
faced with their self-management, and to examine their willingness to use diabetes mHealth apps on their
smartphones to assist with their diabetes management.
Methods. This study employed purposive sampling to select patients for individual interviews. Participant
selection occurred at a Memphis hospital located in an area of town with predominately low-income and
minority residents, as well as a high prevalence of diabetes. Semi-structured interviews were conducted
on-site at the hospital based on McNamara’s interview staging. In all, 15 interviews were recorded,
transcribed, and coded according to the interpretative phenomenological analysis framework.
Results. The data produced 5 topic clusters related to at-home diabetes management, which supported 2
overarching themes, and 7 clusters related to mHealth smartphone app use, which supported 3
overarching themes. The themes related to self-management are as follows: 1. Patients are aware that
successful diabetes control requires active engagement on their part but voiced struggles related to
balancing limited income and a healthy diet, how to manage fluctuating glucose readings throughout the
day, and affording medications; and 2. Lacking a traditional relationship with a primary care doctor, these
underserved patients turn to friends and family, written materials, and the internet as health care
resources. The themes related to smartphone mHealth are as follows: 1. Despite limited knowledge about
health apps and varying phone use patterns, patients were all willing to try at least one diabetes-related
app; 2. App functions should be individualized to meet each patient’s needs for maximum benefit; and 3.
Barriers to app use were varied but commonly included knowledge and technological challenges and
security issues.
Conclusion. Interviews from this vulnerable population demonstrated that individuals understood the
importance of their own active involvement in controlling their diabetes. Yet, because of limited economic
and health care resources, these patients struggle with the implementation of effective lifestyle choices in
their daily routine. Furthermore, interviewees expressed interest in trying mobile health apps for diabetes
management, despite minimal knowledge about the technology. Responses showed that selecting apps
tailored to each individual’s needs, instead of offering one blanket multifunctional app, would provide

patients with the greatest benefit. Smartphone apps may be a low-cost health resource that patients
without regular access to physicians can use for their at-home diabetes management.
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ABSTRACT

Introduction. Diabetes mellitus is a condition with a growing morbidity and mortality
burden. An estimated 30 million adults currently live with diabetes, with each individual
spending over $9500 annually on medical care. The successful management of diabetes is
a lifelong endeavor. This involves balancing a variety of factors including diet,
medications, and glucose monitoring. It has been well established that successful control
of diabetes depends largely upon patients’ daily lifestyle habits and activities. Not all
patients, however, have the resources necessary for effective diabetes management.
Health disparities lead to a higher rate of diabetes development in minority and poor
populations. Since underserved patients have limited access to traditional healthcare
avenues, providers should explore other means, like mobile health (mHealth), to help
such patients. The rapid adoption of smartphones within the last decade has allowed an
opportunity for patients to use mHealth and smartphone applications (apps) as a low-cost
way to get health information and services. mHealth has the potential to address such
disparities in access to health care. Little is known about the effectiveness of using apps
to help underserved patients with their diabetes management. Assessing these patients’
current self-management practices and their interest in using smartphone apps for their
diabetes management is the first step in determining how mHealth may benefit this
patient population.
Purpose. The purpose of this study was to assess how underserved patients with limited
access to primary care physicians handled their diabetes on their own at home, to
determine what challenges they faced with their self-management, and to examine their
willingness to use diabetes mHealth apps on their smartphones to assist with their
diabetes management.
Methods. This study employed purposive sampling to select patients for individual
interviews. Participant selection occurred at a Memphis hospital located in an area of
town with predominately low-income and minority residents, as well as a high prevalence
of diabetes. Semi-structured interviews were conducted on-site at the hospital based on
McNamara’s interview staging. In all, 15 interviews were recorded, transcribed, and
coded according to the interpretative phenomenological analysis framework.
Results. The data produced 5 topic clusters related to at-home diabetes management,
which supported 2 overarching themes, and 7 clusters related to mHealth smartphone app
use, which supported 3 overarching themes. The themes related to self-management are
as follows: 1. Patients are aware that successful diabetes control requires active
engagement on their part but voiced struggles related to balancing limited income and a
healthy diet, how to manage fluctuating glucose readings throughout the day, and
affording medications; and 2. Lacking a traditional relationship with a primary care
doctor, these underserved patients turn to friends and family, written materials, and the
internet as health care resources. The themes related to smartphone mHealth are as
follows: 1. Despite limited knowledge about health apps and varying phone use patterns,
patients were all willing to try at least one diabetes-related app; 2. App functions should
iv

be individualized to meet each patient’s needs for maximum benefit; and 3. Barriers to
app use were varied but commonly included knowledge and technological challenges and
security issues.
Conclusion. Interviews from this vulnerable population demonstrated that individuals
understood the importance of their own active involvement in controlling their diabetes.
Yet, because of limited economic and health care resources, these patients struggle with
the implementation of effective lifestyle choices in their daily routine. Furthermore,
interviewees expressed interest in trying mobile health apps for diabetes management,
despite minimal knowledge about the technology. Responses showed that selecting apps
tailored to each individual’s needs, instead of offering one blanket multifunctional app,
would provide patients with the greatest benefit. Smartphone apps may be a low-cost
health resource that patients without regular access to physicians can use for their athome diabetes management.
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CHAPTER 1.

INTRODUCTION

Background
Diabetes mellitus is a metabolic disease characterized by elevated glucose levels
in the blood. This is due to the body’s inability to produce enough or any insulin, the
hormone necessary to break down glucose, or an inability to properly respond when
insulin is produced. The American Diabetes Association (ADA) defines a diabetes
diagnosis as having a hemoglobin A1c (HbA1c) ≥ 6.5%, a fasting blood glucose ≥ 126
mg/dL, or a two hour postprandial blood glucose ≥ 200 mg/dL (ADA, 2019). Having
persistently high blood glucose levels can lead to a constellation of serious complications
including end stage renal disease (ESRD), stroke, neuropathy, and blindness. Once
developed, diabetes itself is a chronic condition. Consequently, its management is often a
lifelong endeavor. Successful diabetes control extends beyond glycemic control; it
involves a whole host of factors ranging from a consistent patient-provider relationship to
regular physical activity.
Not all individuals with diabetes, however, have access to an adequate arsenal of
resources needed for effective disease control. Health disparities either related to race,
income, or other social environmental constraints contribute to a higher frequency of
diabetes development in poor and racial and ethnic minority populations. Moreover,
health care disparities limit the care these patient populations receive. This then leads to
lack of knowledge about diabetes itself and an inability to form a consistent relationship
with an ambulatory care team. Ultimately, a lack in care and attention toward the disease
leads to both costly emergency and hospitalization services and major organ damage.
Because underserved populations have little to no access to traditional means of
healthcare, providers must explore other avenues to reach this patient group.
Mobile health (mHealth), or the practice and delivery of health care via mobile
devices like cell phones, tablets, or wearable electronics, has grown significantly in the
last decade. With the fast-paced adoption of cell phones, mobile health presents the
opportunity to offer patients with diabetes a low-cost way to receive health information,
to communicate with providers, and to self-manage different chronic conditions. It has
been well established that low-income, racial and ethnic minority populations experience
several barriers to receiving basic health care including uninsurance, limited
transportation, and high out-of-pocket costs. The provision of health care via mobile
devices may have the potential to address such health disparities. Over 90% of American
adults now own a cell phone; 81% say that their cell phone is a smartphone (Pew
Research Center (PRC), 2019). As noted in Table 1-1, there is no significant difference
in smartphone ownership by race. While those with lower income and education and
those of older age are less likely to own a phone compared to their counterparts, the vast
majority still demonstrated ownership. This ownership offers an opportunity for mHealth
to overcome access barriers in diabetes care delivery.
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Table 1-1.

Percent of adults by demographic who own smartphones

Demographic
Gender
Female
Male
Age
18-29
30-49
50-64
≥65
Race
White
Black
Hispanic
Highest Education Level
Less than high school graduate
High school graduate
Some college
College graduate
Income
<$30,000
$30,000-$49,999
$50,000-$74,999
≥$75,000

Smartphone ownership
79%
84%
96%
92%
79%
53%
82%
80%
79%
66%
72%
85%
91%
71%
78%
90%
95%

Modified with permission. Pew Research Center. Mobile fact sheet (12 Jun 2019).
https://www.pewresearch.org/internet/fact-sheet/mobile/ (accessed 30 Jun 2019).
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Statement of the Problem
Diabetes is a chronic condition experiencing rapid growth in the United States.
According to the latest statistic report from the Centers for Disease Control and
Prevention (CDC) (2017), over 9% of the US population, about 30.3 million Americans,
are currently living with diabetes. An estimated 1.5 million adults are newly diagnosed
diabetes each year. Additionally, about 24% of all diabetes cases remain undiagnosed,
meaning that an additional 7.2 million Americans are unaware of their condition. Left
unmanaged, the condition often leads to increased morbidity from common
complications like renal failure or amputation. Diabetes remains the seventh leading
cause of death in the US (CDC, 2017).
In addition, economic and social disadvantages contribute to health disparities in
the diabetes. This means that individuals with certain socioeconomic characteristics are at
higher risk of developing diabetes. Groups who experience health disparities have an
increased burden of illness, disability, injury, or mortality compared to others. In the case
of diabetes, poverty, minority race, and low education level all serve as independent risk
factors for developing the disease (Geiss et al., 2014; Beckles & Chou, 2016; CDC, 2017,
Gaskin et al., 2014).
Along with disparities in diabetes development, there also exist disparities in
accessing health care for the disease. Minority and low-income populations often lack the
proper resources and treatment necessary for successful blood glucose control. When
compared to whites (13% uninsured), blacks (21%), Hispanics (32%), and American
Indians (27%) demonstrate higher rates of uninsurance (Kaiser Family Foundation
(KFF), 2012). Low-income populations (32% of those with income under the federal
poverty level (FPL)), as well, have a higher rate of uninsurance compared to those with
higher incomes (15% for income between 200 and 399% FPL, 5% for income ≥ 400%
FPL) (KFF, 2012). As a result, these low-income and racial and ethnic minority
populations experience more barriers to accessing care and poorer quality care. More
African Americans, Hispanics, and Asians cite the emergency room as their usual source
of care compared to whites, and conversely, were less likely than whites to indicate a
doctor’s office or private clinic as their primary care source (Mead et al., 2008). The
percentage of people with a source of ongoing care to help their health management is
significantly lower for those with low income (77.5% vs. 92.1% for high-income groups)
and also lower for those with less education (74.2% for those with less than a high school
education vs. 82.2% for those with some college education) (Agency for Healthcare
Research and Quality, 2010).

Importance of Diabetes Self-Management
The successful management of diabetes extends beyond a few doctor’s visits and
check-ups. It involves the development of a well-informed patient who is able and willing
to make daily lifestyle adjustments. The use of smartphones and mobile health may help
in creating an informed and actively engaged patient, a marker of successful chronic
disease management. Successful management of chronic illnesses extends beyond usual

3

care office visits with a physician (Wagner, 1998). A large contributor to the deficiencies
in chronic disease care is a healthcare system that prioritizes the urgency of quelling
acute symptoms over the long-term commitment to optimize control of chronic
conditions. In a system ill equipped to address the chronic nature of diabetes, patients
became passive and uninformed with only brief, sporadic visits with ill-prepared health
care providers (Bodenheimer, Wagner, & Grumbach, 2002).
Successful chronic care means demanding quality not just from health care
providers and the overarching health system but also from the community-at-large
(Bodenheimer, Wagner, & Grumbach, 2002). In addition to improving patient care via
traditional elements like using evidenced-based guidelines to make daily practice
decisions or promoting team-based care in a health care organization, elements that
empower the patient himself like offering self-management support and community
resources outside the health care environment are equally as important (Coleman et al.,
2009). The end goal is to produce an informed, engaged patient (Wagner, 1998). In this
way, providing patients with the resources and knowledge to take care of their diabetes
throughout their daily lives is just as meaningful as traditional patient-provider
interactions.
As this study focused on the management of a chronic condition, diabetes, via
mobile resources, it addressed two elements of patient empowerment: the provision of
health resources outside a health care setting and self-management support. The
population included in the study has limited access to traditional ambulatory and primary
care physician (PCP) offices. Thus, for these underserved patients, it is prudent to
capitalize on what resources they do have to manage their health. These resources would
be their smartphones, which unlike health care systems, are something they engage with
every day. This study sought to explore whether this vulnerable population might be
receptive to obtaining health care information and resources via smartphones to help
increase their self-management skills. The effectiveness of a patient’s ability to control
his disease progression is often the largest determinant of his health outcomes. Selfmanagement is the ability of the patient to make autonomous choices regarding his health
(Bodenheimer et al., 2002). It addresses the patient question of “What can I do to manage
my diabetes?” The concept of patient empowerment dovetails with self-management.
Empowerment involves giving patients the tools, problem-solving skills, and confidence
necessary to take responsibility for their diabetes (Bodenheimer et al., 2002). By
providing patients with mHealth resources, this study aimed to foster a transition from
passive, provider-driven decisions (“My doctor wants me to take my medications.”) to
active, patient-driven ones (“It is important to me to take my medications.”).

Opportunity for Smartphone mHealth
The smartphone has been one of the fasting growing and adopted technologies in
the past decade. Compared to 35% ownership in 2011, 81% of American adults in 2019
now own a smartphone (PRC, 2019). What makes the smartphone such a desirable
resource is its ability to offer multiple functions in a portable device. In fact, most
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smartphone owners use their devices for more than just calls. Over 80% of owners use
their phones to text, check e-mail, and access internet; over 55% also use them for social
networking, watching videos, and news. Almost all smartphone owners, 99%, used their
devices at home. The majority of smartphone owners also view their devices as a
valuable resource. Positive attitudes included 93% deeming their phones as helpful, 80%
as worth the cost, and 72% as connecting (Smith, 2015).
Unlike traditional healthcare services, the smartphone is a resource that is readily
available and used by minority and low-income populations. Of note, 62% of smartphone
owners have already used their phones to find information about a health condition
(Smith et al., 2015). As shown in Table 1-1, almost the same percentage of minorities
(80% of blacks, 79% of Hispanics) own a smartphone compared to whites (82%). While
smartphone ownership rises with increased income, a good majority, over 70%, of those
in the lowest income bracket, earning <$30,000 per year, indicated smartphone
possession (PRC, 2019). With increased smartphone ownership also comes an increase in
smartphone dependency. Currently, 37% of American adults mostly use their
smartphones to access the internet. Additionally, 17% are completely smartphonedependent; their phones are the only means to go online at home (Anderson, 2019).
Those who are minority or with the lowest income display more dependency (Table 1-2).
Accordingly, this data shows that there exists an opportunity to engage lower income and
racial and ethnic minority populations via a mobile health platform.

Overall Purpose of the Study
The purpose here was twofold. First, this study aimed to determine how
underserved patients with limited access to PCPs currently self-managed their diabetes at
home and any challenges they face with their self-management. Second, the study aimed
to assess the interest in and feasibility of using smartphone applications (apps) to help
low-income, disadvantaged patients in the Memphis area manage their own healthcare.

Study Objectives
Study objectives and respective research question were:
1. Determine what patients are currently doing at home to manage their diabetes.
a. What habits or routines have they developed regarding their diabetes?
b. What do patients identify as challenges or struggles with managing their diabetes at
home?
2. Explore the attitudes toward and interest in the use of mobile health technology in an
underserved population.
a. What do patients know about apps for diabetes?
b. How confident or comfortable are patients with using smartphones and mHealth?
c. How do patients feel about using their smartphones on a routine basis to monitor
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Table 1-2.

Percent of adults by demographic who are smartphone dependent

Demographic
Gender
Female
Male
Age
18-29
30-49
50-64
≥65
Race
White
Black
Hispanic
Highest Education Level
Less than high school graduate
High school graduate
Some college
College graduate
Income
<$30,000
$30,000-$49,999
$50,000-$74,999
≥$75,000

Smartphone dependency
16%
17%
22%
18%
14%
12%
12%
23%
25%
32%
24%
18%
4%
26%
20%
10%
6%

Modified with permission. Pew Research Center. Mobile fact sheet (12 Jun 2019).
https://www.pewresearch.org/internet/fact-sheet/mobile/ (accessed 30 Jun 2019).
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their diet, exercise, medications, and blood glucose?
3. Assess patients’ willingness to download and continue using a health app on their
smartphones.
a. What app functions do patients have the most interest in using?
b. Would patients be willing to pay for an app download?
c. How frequently would patients continue to use mobile health apps?
d. What would stop patients from downloading or continuing to use an app?
Assumptions
The study included the following assumptions:
1. Each participant completely answered all study questions honestly and to the best of
his ability.
2. The study population represented the target population.
Limitations
For this study, the following limitations existed:
1. Findings may only be limited to the Memphis sample population and not
generalizable to the greater US population.
2. Because this was a pilot study, findings were exploratory and longer, more rigorous
studies may be needed to determine any clinical benefits of smartphone health apps.
3. Findings may be limited only to diabetes apps discussed in the study and not
generalizable to other healthcare apps with similar functions.
Relevance to Health Outcomes Research
An intensive search of the literature shows that very little has been published
about leveraging mHealth to address health disparities. There has been much suggestion
about the potential of using smartphone apps to improve health outcomes among the
disadvantaged population (Kratzke & Cox, 2012; Luxton et al., 2011; Moore, 2012), but
research in this area is still nascent. Nonetheless, smartphones have the potential to act as
a new vehicle for health information and care where patients have had longstanding
access barriers to the more traditional brick-and-mortar physician office.
The smartphone has the potential to bridge the divide between the low-income,
racial and ethnic minority populations and health care services. Some 46% of all
smartphone owners prefer to use their phones over any other devices for going online. Of
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the 27% of Americans who do not have broadband internet at home, 45% state the reason
for not having home internet is that their smartphone “lets them do everything they need
to do online” (Anderson, 2019). The demographics of these smartphone-only internet
users (Table 1-2) align with those of the healthcare disadvantaged: low-income, lesseducated, and minority. Therefore, the provision of health services through this already
existing mobile platform may help provide care to a patient group that has struggled to
obtain care through traditional means.
As of yet, there is no literature on the use of smartphone apps in underserved
populations to address diabetes management. This study hopes to provide the following
the original contributions: 1. Determine the ability of a traditionally resource-limited
population to access and use diabetes smartphone applications, and 2. Gauge patients’
willingness to accept apps to manage their diabetes. Ideally, the results from this study
will act as a springboard for the development of further research on utilizing smartphone
health applications in a resource-limited patient population.
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CHAPTER 2.

LITERATURE REVIEW

Introduction
Diabetes mellitus carries an ever-growing onus of morbidity and mortality in the
United States. The cost is substantial: billions of dollars each year go toward the
treatment of diabetic emergencies and complications. Optimal management and control
of the disease are key to reducing this burden. Successful diabetes control, however,
extends beyond drug therapy. In order to understand the totality of diabetes management,
a review of the 2019 guidelines from the American Diabetes Association is below.
Because the study population contains mainly minority patients, an examination of the
disparity in diabetes control between blacks/Hispanics and white follows. Then a review
of mHealth use for diabetes management and mHealth use in disadvantaged populations
presents what is known so far about cell phone use to provide health care. Finally, a brief
discussion of the relationship between self-management and diabetes outcomes highlights
why an active, informed patient is necessary for clinical control.

Prevalence and Cost of Diabetes
In the 20 years from 1990 to 2010, the number of American adults living with
diabetes more than tripled from 6.2 to 20.9 million (CDC, 2019). Of these individuals,
about 90-95% have type 2 diabetes mellitus (T2DM), while the remaining 5% have type
1 diabetes mellitus (T1DM) (CDC, 2017). An estimated 1.5 million adults are newly
diagnosed each year (CDC, 2017). In total, about 10% of the American population has
diabetes; if the present trend continues, up to 1 in 3 Americans will have diabetes by
2050 (Boyle et al., 2010). Once affected, patients with diabetes carry a significant,
lifelong health burden. If diagnosed early at age 10, boys will lose, on average, 18.7 total
life-years and 31 quality-adjusted life years (QALYs); girls will lose, on average, 19 total
life-years and 32.8 QALYs (Narayan et al., 2003). Even when diabetes is diagnosed later
in life, the disease still has a marked morbidity and mortality impact. If diagnosed at age
60, men would lose 7.3 life-years and 11.1 QALYs; women would lose 9.5 life-years and
13.8 QALYs (Narayan et al., 2003). Diabetes is responsible for over 14 million
emergency department (ED) visits annually and is the seventh leading cause of death in
the United States (CDC, 2017).
Along with the health costs, the economic costs for diabetes are just as great. In
the 5 years from 2012 to 2017, the cost of diabetes rose 26% (ADA, 2018). For 2017,
diagnosed diabetes carried a cumulative cost of $327 billion, with $237 billion in medical
costs and $90 billion in diminished productivity costs (ADA, 2018). This amount
represents an 88% increase in the decade from 2007 to 2017 (ADA, 2013; ADA, 2018).
People with diabetes spend an average of $16,750 per year on health care costs, of which
over half, $9,600, goes toward diabetes-related care; in fact, they spend 2.3 times more
money on health care than they would have in the absence of diabetes (ADA, 2018).
Individuals diagnosed with diabetes at age 40 spent $124,600 more on medical

9

expenditures throughout the rest of their lifetime than those without diabetes; those
diagnosed later at age 60 still spent $53,800 more (Zhou et al., 2014). There also exist
disparities in the cost of diabetes. Compared to those with insurance, people with diabetes
who are uninsured experience 79% fewer physician visits but have 55% more ED
encounters; African Americans have 75% more ED visits than the diabetes population as
a whole (ADA, 2013). Inpatient hospital costs are also 41.3% higher for black patients
with diabetes than whites (ADA, 2013). Overall, the economic burden is substantial with
1 in every 4 health care dollar spent on caring for someone with diagnosed diabetes
(ADA, 2018).
Guidelines for Diabetes Management
The American Diabetes Association published the most current diabetes
management guidelines, Standards of Medical Care in Diabetes, in 2019. The ADA
standards are further augmented by the most recent clinical practice guidelines from the
American Association of Clinical Endocrinologists (AACE). The ADA recognizes four
distinct categories of diabetes: Type 1 (absolute insulin deficiency), type 2 (insufficient
insulin production that leads to resistance), diabetes of other origins (i.e. drug- or diseaseinduced), and gestational diabetes (diagnosed only during pregnancy). Diagnosis of
diabetes depends on having at least one of these three criteria: hemoglobin A1c ≥ 6.5%,
fasting blood glucose ≥ 126 mg/dL, or a two hour glucose ≥ 200 mg/dL during an oral
glucose tolerance test (ADA, 2019; AACE, 2015).
In addition to screening and diagnosis recommendations, the guidelines focus on
therapeutic actions that both patients and providers must take to achieve optimal diabetes
control. Once diagnosed, a patient should form a “collaborative therapeutic alliance”
(ADA, 2014) with his family, physician, and health care team to produce the most
comprehensive care. The guidelines strongly urge that all treatment goals and plans
follow patient preferences and needs. This patient-centered approach extends to the
selection of drug therapy as well. Because T1DM occurs when the pancreas is unable to
produce insulin, medication treatment options are generally limited to long acting basal
insulins and shorter acting, prandial insulins (ADA, 2019). T2DM, however, has a variety
of drug therapy choices available. Whereas previous versions of the ADA guidelines
provided a stepwise, more prescriptive approach to selection of medications for T2DM
(Nathan et al., 2009), the guidelines from 2014 onward are less rigid (ADA, 2014; ADA,
2019). Based on extensive evidence of its safety and efficacy, metformin remains the first
preferred medication. If after three months on maximum dose single agent therapy the
patient does not have adequate blood glucose control, then a second medication, and if
needed, a third, may be added to the patient’s medication regimen (ADA, 2019). Other
oral medications used to treat T2DM may include sulfonylureas (e.g. glyburide),
thiazolidinediones (e.g. pioglitazone), DDP-4 inhibitors (e.g. sitagliptin), GLP-1 receptor
agonists (e.g. liraglutide), meglitinides (e.g. nateglinide), and SGLT2 inhibitors (e.g.
canagliflozin) (Tran et al., 2015). More complex therapy may involve both basal (e.g.
glargine) and shorter acting (e.g. aspart) insulin when noninsulin therapy is not enough to
achieve glucose goals (AACE, 2015). Selection of any medication should not be based on
efficacy alone. Pharmacological therapy decisions should take into consideration patient-
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specific factors like side effects tolerability, weight and comorbidities, out of pocket
costs, and daily pill burden (ADA, 2019).
For most non-pregnant adults, the ADA recommends targeting HgA1c <7%.
Fasting blood glucose should be between 80-130 mg/dL, and postprandial glucose should
be ≤ 180 mg/dL (ADA, 2019). To target achievement of these goals, patients should
engage in regular self-monitoring of blood glucose (SMBG). Controlling blood glucose
to within these goals is crucial to delay the onset of micro- and macrovascular
complications associated with diabetes. SMBG is an important component of patient selfmanagement. When done routinely, SMBG can facilitate better diabetes control by
improving patients’ awareness of hypo- and hyperglycemia, allowing patients and
providers to create an individualized medication regimen based on how that patient’s
glucose fluctuates throughout the day, and empowering patients to make appropriate diet
and exercise decisions based on their daily glucose values (Benjamin, 2002). The
guidelines recognize that SMBG plays an integral role in helping patients achieve their
glycemic goals but also states that each patient’s specific routines and needs should
determine SMBG timing and frequency (ADA, 2019; AACE, 2015).
The current guidelines recognize that medication therapy alone is not sufficient
for chronic diabetes management. Lifestyle modifications are a recommended therapy for
all patients, regardless of disease severity, and “all people with diabetes should
participate in diabetes self-management education to facilitate the knowledge, skills, and
ability necessary for diabetes self-care” (ADA, 2019). Therapeutic lifestyle modifications
range from diet and nutrition planning to tobacco cessation. In order for these
modifications to have any efficacy, patients must receive the proper education, resources,
and motivation to make and sustain changes to their daily routine. Lifestyle changes
should also be individualized to each patient’s needs and experiences (ADA, 2019;
AACE; 2015). A summary of the recommended lifestyle improvements for diabetes
management is listed in Table 2-1.

Disparities in Diabetes Development
It is well established in the literature that individuals of low socioeconomic status
(SES) possess an increased risk of developing diabetes. As discussed previously, diabetes
prevalence continues to rise every year. Yet this growth disproportionately affects those
of lower SES. Lower education levels are associated with a higher diabetes prevalence.
While only 7.2% of adults with more than a high school education have diagnosed
diabetes, 9.5% of adults with a high school education and 12.6% of adults with less than
a high school education have diagnosed diabetes (CDC, 2018). Similar to education,
diabetes prevalence is inversely related to household income level. Adults living in the
poorest households at FPL < 200% have the highest rate of diabetes at over 12%; adults
at FPL ≥ 200% and < 300% have an 11% rate, adults at FPL ≥ 300% and < 400%, a 9%
rate, and adults at FPL ≥ 400%, a 5% rate (Gaskin et al., 2014). Furthermore, in a study
that analyzed the relationship between poverty, education, and occupational status and
T2DM prevalence among black and non-Hispanic white adults age 40-74, low income
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Table 2-1.

Summary of lifestyle modifications for diabetes self-management

Modification
Diet

Recommendations
Understand and use information presented in Nutrition Facts Label
for foods.
Monitor carbohydrate intake by either counting or by experiencebased estimation.
Choose fruits, vegetables, legumes, whole grains, and dairy as a
carbohydrate source over other high in fats, sugars, or sodium.
Consume foods with long-chain n-3 fatty acids (i.e. fatty fish or nuts)
over those with lots of trans or saturated fat.
Limit or avoid intake of sugar-sweetened (i.e. high fructose corn
syrup or sucrose) beverages.

Alcohol

Limit consumption to a maximum of 1 drink for women and 2 drinks
for men per day.

Salt intake

Restrict daily sodium intake to <2,300 mg/day.
Further sodium restriction may be taken for adults with both diabetes
and hypertension.

Weight loss

For overweight or obese adults with diabetes, moderate weight loss of
about 5% of body weight may have clinical benefit.
Avoid fasting as a technique to encourage weight loss; caloric
reduction with regular meals and snacks is preferred.

Exercise

Perform ≥ 150 minutes/week of moderate intensity exercise spread
over at least 3 days/week and resistance training at least 2 days/week.
Reduce daily sedentary behavior; interrupt prolonged sitting every 30
minutes with light physical activity.

Mental health

Practice stress reduction techniques.
Use family and social support to help with diabetes self-management.
Maintain regular sleep habits to ensure optimal sleep quality and
quantity.

Tobacco

Avoid use of all tobacco products, including cigars, cigarettes,
chewing tobacco, as well as e-cigarettes.
For tobacco users ready and willing to quite, engage in active
smoking cessation counseling and pharmacotherapy as needed.

Data Sources: American Association of Clinical Endocrinologists. Clinical practice
guidelines for developing a diabetes mellitus comprehensive care plan. Endocrine
Practice. 2015; 21(1):1-87; American Diabetes Association. Standards of medical care in
diabetes—2019. Diabetes Care. 2019; 42(Suppl. 1):S1–S186.
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was the socioeconomic factor most strongly associated with diabetes development; this
association presented itself with both whites and blacks and occurred largely independent
of other risk factors (Robbins et al., 2001).
Minority race also serves as a risk factor for diabetes development. For instance,
while 7.4% of all non-Hispanic whites age 18 and over have diabetes, 12.7% of blacks,
12.1% of Hispanics, and 8% of Asians adults have diabetes (CDC, 2018). African
Americans with the lowest socioeconomic status are four times more likely to develop
diabetes when compared to whites (Brancati et al., 1996). Data provided by the Office of
Minority Health (OMH), a division of the Department of Health and Human Services,
show Asian Americans as 40% more likely to be diagnosed with diabetes than whites
(2019a). Hispanic adults too are 1.7 times more likely to be diagnosed compared to
whites (OMH, 2019b). Even after controlling for racial differences in age, SES, and
weight, blacks still hold twice the risk of having diabetes compared to whites (Brancati et
al., 1996). This indicates that minority race appears as an independent risk factor for
diabetes.

Disparities in Diabetes Control
Akin to the differences seen in the prevalence of diabetes, there also exist
disparities in the maintenance of the condition and related comorbidities. For minority
patients, differences in quality of care often lead to poorer diabetes control. Black and
Hispanic individuals with diabetes are less likely to self-monitor their blood glucose and
consequently, more likely to have a HbA1c ≥ the ADA goal of 7% (Harris et al., 1999).
When compared to whites, Hispanics are less likely to receive non-oral diabetes
medications and to check for foot sores or ulcers (Thackeray et al., 2004). African
American patients are more likely to experience what is termed “clinical inertia” (Cook et
al., 1999); this is when providers fail to step up medication therapy despite compelling
clinical indications. Patients who encounter clinical inertia have worse diabetes control
(Cook et al., 1999). Other studies have confirmed that compared to whites, Hispanics and
African Americans with diabetes receive less testing and treatment for comorbid
conditions like hypertension and dyslipidemia (Arday et al., 2002; Hertz et al., 2006;
Massing et al., 2003).
Moreover, racial and ethnic minority groups experience higher rates of
developing diabetes-related complications and even death. In contrast to Caucasian adults
with diabetes, African Americans showcase more obesity and central adiposity (Brancati
et al., 1996). African Americans have about 2-4 times more kidney disease, blindness,
and amputations than Caucasians (Carter et al., 1996; Lanting et al., 2005). Specifically,
African Americans are 50% more likely to develop diabetes-related retinopathy (Chow et
al., 2012) and have a 2.6 times higher rate of end stage renal disease (ESRD) than
Caucasians (Perneger et al., 1994). Blacks with diabetes are 1.5 times more likely to
become hospitalized than whites (Chow et al., 2012). Hispanics, as well, demonstrate
higher rates of renal disease and retinopathy (Carter et al., 1996; Lanting et al., 2005;
Emanuele et al., 2005). Similarly, Asian Americans are 80% more likely to have
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diagnosed ESRD than Caucasians (OMH, 2019a). Socioeconomic disparities carry over
to diabetes-related mortality, as well. Compared to adults with the highest income (4x the
federal poverty level), those with family incomes under the poverty level have over a
two-fold higher mortality rate (Saydah & Lochner, 2010).

mHealth and Diabetes Management
The rising adoption of mobile technology has created the opportunity for patients
to leverage their own cell phones as a health care resource. Recent research indicates that
more and more people are using their mobile devices for more than just calling. In
addition to placing and receiving calls, a majority of cell phone owners report using their
devices to send/receive text messages, browse the internet, send/receive e-mails, and
download mobile applications (Smith, 2015). Almost 20% of smartphone owners are
completely dependent on their phones as their only source of internet (Anderson, 2019).
Similar to the disparities discussed above with diabetes care and development,
smartphone internet dependency presents more in lower income and racial and ethnic
minority populations. While only 6% of adults with an annual income of at least $75,000
reported smartphone-only internet access, 26% of adults making less than $30,000
annually reported smartphone internet dependency (Anderson, 2019). Minorities, as well,
rely more on their smartphones as their only source of internet. Compared to just 12% of
white, 23% of blacks and 25% of Hispanics are smartphone-only internet users
(Anderson, 2019).
An emerging resource in the healthcare arena, smartphone applications (apps) are
a potential low cost tool to benefit individuals in the self-management of their diabetes.
The overwhelming majority of health apps, 84%, are available for consumer download at
no cost; when there is a charge, the average per download is around $2 (IQVIA Institute
for Human Data Science (IQVIA), 2015). Mobile health technology has grown
tremendously in the past decade. Seventy-five percent of American adults state that
technology is important for their health management (Accenture, 2018). In the four years
from 2013 to 2017, the number of commercially available health apps for download has
nearly quintupled from about 66,000 to 318,000 (IQVIA, 2017). Comparatively, in the
four years from 2014 to 2018, the percentage of adults reporting the use of a mobile
health app has tripled from 16% to 48% (Accenture, 2018). The continued expansion of
mHealth has led the Food and Drug Administration (FDA) to create guidelines for the
approval and regulation of healthcare apps, especially those that act as a mobile platform
for a medical device (FDA, 2019). With over 1,000 apps available for Android or iOs
download (Research2guidance, 2014), diabetes represent 16% of all disease-specific apps
(IQVIA, 2017). This makes it the second most common disease state represented among
all apps (Figure 2-1). Despite the large volume of apps available, several barriers exist to
patients’ use including lack of knowledge and limited to no provider input. For those that
choose to download an app, they may make that decision based on whether the app seems
most popular in the online store and not based on the functions they most need to help
manage their diabetes. While the literature shows continued growth and development of
diabetes smartphone apps, there is little research focused on how patients with diabetes
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Figure 2-1. Percentage of disease-specific apps by disease type
Modified with permission. IQVIA Institute for Human Data Science. The growing value
of digital health: Evidence and impact on human health and the healthcare system (Nov
2017). https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/the-growing-value-ofdigital-health.pdf?_=1599234197223 (accessed 2 Apr 2018).
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select what health apps to download. This is an area this study addresses.
Recent literature has indicated the potential boon mobile apps may be on
patients’ diabetes self-management. A recent review of available diabetes apps on the
market shows that most common features include insulin/medication recording,
automatic data entry & communication, diet recording, and weight management (Conway
et al., 2016; Tran et al., 2012). Table 2-2 lists the different app functions available for
diabetes management. There are a limited number of American studies available that
have examined the effect of mobile app use to augment diabetes self-management.
Nonetheless, they have demonstrated positive results. One, which looked at the use of
WellDoc, an FDA-approved app that provides real-time feedback to physicians on
patients’ blood glucose, keeps tracks of medication regimens, and provides hypo- and
hyperglycemia treatment algorithms, in a randomized controlled trial that compared app
use to usual care. After three months, participants in the intervention group saw a
significant reduction in their A1c levels (2.03% vs. 0.68%) and also had more medication
titrations/changes (84% vs. 23%) from their healthcare providers (Quinn et al.,
2008). Another randomized trial examined the use of a popular and commercially
available application, Glucose Buddy, in helping patients with diabetes manage their
chronic condition. At the conclusion of the nine month study, the patients who utilized
the app had a significant improvement (7.8%) in their A1c levels from baseline (9.08%)
compared to the patients in the control group (8.58% at follow-up, 8.47% at baseline)
(Kirwan et al., 2013). For studies conducted outside the United States on the effects of
using smartphone diabetes apps, Table 2-3 provides a summary. Results from these
studies demonstrate an overall benefit from app use not only on clinical measures like
HbA1c but also on quality of life (QOL) measures like confidence and self-efficacy.

Self-Management in Diabetes
Broadly, the concept of self-management involves a patient developing adequate
knowledge and skills to keep their blood glucose at goal. In practice, self-management
encompasses a wide variety of aspects like developing competence to interpret blood
glucose numbers, properly using a blood glucose machine, monitoring for symptoms of
hypo- and hyperglycemia, and maintaining a healthy diet/exercise regime. The American
Diabetes Association considers success self-management so crucial to chronic diabetes
control that it publishes and updates yearly national guidelines for diabetes selfmanagement (ADA, 2019).
These guidelines outline different standards related to physical fitness, nutrition,
and general wellness that patients and providers should strive to meet. Mobile health apps
may help patients in an at-home setting with their self-management. Because the majority
of patients with diabetes do not receive much structured diabetes education, it is crucial
first to acknowledge and then to help patients overcome any barriers to receiving support.
This may often “entail identifying resources outside the provider’s practice that can assist
in the ongoing support of the participant” (Haas et al., 2012). mHealth apps provide an
avenue through which patients with no or limited access to traditional primary care
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Table 2-2.

App functionality in relation to diabetes

App function
Educate

Application to diabetes
Provide general information related to the overall disease state,
including pathophysiology, risk factors, and differences between
the major types.
Can be presented in text, video, animation, or picture format.

Direct

Give instructions to users on how to perform diabetes-related tasks
like administering insulin or finger sticks for glucose monitoring.
Can be presented as a stepwise list or as how-to videos.

Record

Store user-entered data regarding caloric intake, physical activity,
or glucose readings.

Display

Generate visual representation as graphs or charts of user generated
data.

Alert

Notify users with reminders to do tasks at certain times like taking
medications or checking blood glucose.
Provide signals or alarms for values that are out of normal range
like blood glucose.

Communicate

Send messages or data between health care providers and patients.
Can be for asking questions to providers, requesting refills from
pharmacies, or making new health appointments.

Modified with permission. IQVIA Institute for Human Data Science. Patient adoption of
mHealth: Use, evidence and remaining barriers to mainstream acceptance (Sept 2015).
https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/patient-adoption-ofmhealth.pdf (accessed 1 Feb 2017).
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Table 2-3.

Summary of randomized controlled trials on diabetes app use

Authors and
year
Berndt R,
Takenga C,
Preik P, et al.,
2014

Charpentier G,
Benhamou PY,
Dardari D, et
al., 2011

Country
Germany

Study
length
1 month

France

6 months

Diabetes
Primary
type
outcome(s)
Type 1 HbA1c levels,
weight, and QOL
satisfaction
measured by the
DQOLY

Type 1

HbA1c levels in
patients with
baseline HbA1c
≥ 8%
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Intervention

Control

Results

Use of the Mobil
Standard
Diab app to track
care
SMBG values and
interfaces entered
information in real
time to medical
staff

Both groups had a
significant decrease
in HbA1c. The
control group had a
significant increase
in weight and BMI
vs. no change in the
Mobil Diab group.
No QOL changes in
the control group.
The Mobile Diab
group reported
significantly greater
self-efficacy scores.

Use of the Diabeo
smartphone
software and
quarterly follow
up OR use of the
Diabeo software
with teleconsults
and no in-office
follow ups

Mean HbA1c was
significantly lower
in the Diabeo
software +
teleconsults group
vs. control (8.41 vs.
9.1). The Diabeo
software alone
produced a 0.67%
HbA1c reduction.

Usual inoffice
quarterly
follow up

Table 2-3.

(Continued)

Authors and
year
Drion I,
Pameijer LR,
van Dijk PR, et
al., 2015

Country

Study
Diabetes
Primary
length
type
outcome(s)
Netherlands 3 months Type 1 Change in QOL
measured by the
RAND-36
questionnaire

Intervention

Control

Use of the
Diabetes Under
Control digital
diary app

Use of a
standard
paper diary

No difference in
QOL between the
groups.

Standard
care

No difference in
HbA1c between the
groups. For patients
doing SMBG ≥ 5
times daily, there
was a significant
HbA1c decrease in
the bant user group
vs. control (0.58%
vs. 0.06%).

Goyal S, Nunn
CA, Rotondi M,
et al., 2017

Canada

1 year

Type 1

HbA1c levels

Standard care +
use of bant, a
blood glucose
tracker app with
out-of-range
glucose alerts and
coaching for outof-range causes
and fixes

Holmen H,
Torbjørnsen A,
Wahl AK, et al.,
2014

Norway

1 year

Type 2

HbA1c levels

Use of the Few
No app use
Touch Application or phone
digital diary app
counseling
OR use of app and
4 months of phone
health counseling
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Results

All groups
experienced a
decrease in HbA1c
from baseline.
Differences
between groups
were not significant.

Table 2-3.

(Continued)

Authors and
year
Huang Z, Tan
E, Lum E, et al.,
2019

Country
Singapore

Study
length
3 months

Diabetes
Primary
type
outcome(s)
Type 2 Medication
adherence
measured by the
ASK-12

Intervention

Control

Results

Standard care +
use of the
Medisafe
medication
reminder app

Standard
care

The intervention
group reported more
adherence with the
app and significantly
lower adherence
barrier scores.

Nagrebetsky A,
Larsen M,
Craven A, et al.,
2013

United
Kingdom

6 months

Type 2

Self-titration of
oral diabetes
medications

Use of t+diabetes/
t+medical digital
diary app with real
time feedback on
graphed SMBG
levels

Medication
titration via
standard
care

86% of intervention
patients vs. 57% of
control patients
made changes to
their medication
regimen based on
glucose readings.

Orsama AL,
Lähteenmäki J,
Harno K, et al.,
2013

Finland

10 months

Type 2

HbA1c levels,
weight, and
blood pressure

Use of the Monica
app, which
provides graphs
and feedback
communication
from nurses based
on entered blood
pressure, weight,
exercise, and
glucose values

Standard
care with
diabetes
education
and
counseling

The intervention
group saw a
significantly greater
HbA1c decrease
(−0.4% vs. +0.036%
for the control
group) and weight
reduction (−2.1 kg
vs. +0.4 kg). There
was no difference in
blood pressure.
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Table 2-3.

(Continued)

Authors and
year
Rossi MC,
Nicolucci A, Di
Bartolo P, et al.,
2010

Country

Waki K, Fujita
H, Uchimura Y,
et al., 2014

Japan

Italy

Study
Diabetes
Primary
length
type
outcome(s)
6 months Type 1 Time required
for education and
treatment &
QOL satisfaction
measured by the
WHO-DTSQ &
SF-36,
respectively

3 months

Type 2

HbA1c and
fasting blood
glucose levels

Intervention

Control

Results

Use of a
smartphone
Diabetes
Interactive Diary

Standard
Education time was
carbohydrate 6 hours for the
counting
intervention and 12
hours for the control
group. Intervention
group had
significantly higher
score increases for
treatment
satisfaction and
QOL measures.

Use of the
DialBetics
smartphone
software

No
smartphone
software use

HbA1c fell 0.4% in
the Dialbetics group
vs. an increase of
0.1% in the control.
Fasting glucose
changes were also
significant in the
Dialbetics group
(−5.5 mg/dl vs.
+16.9 mg/dl in the
control).

Notes: QOL = quality of life; DQOLY = Diabetes Quality of Life for Youth scale; BMI = body mass index; ASK-12 = Adherence
Starts with Knowledge 12 questionnaire; WHO-DTSQ = World Health Organization-Diabetes Treatment Satisfaction Questionnaire;
SF-36 = 36-Item Short Form Health Survey
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services can access self-management resources. Additionally, mHealth carries the
advantage of offering a variety of support functions ranging from medication adherence
to diet/carbohydrate monitoring. Such a diverse offering dovetails with the concept of
management individualization. Patients with diabetes comprise a heterogeneous
population, differing in cultural, educational, and psychosocial backgrounds. Therefore,
self-management support must be tailored to each patient’s needs in order to be effective
(Haas et al., 2012). With smartphone applications, patients are able to pick and choose
from hundreds of apps those that are relevant to their lifestyle and health goals.
Numerous clinical trials have demonstrated the benefits of developing selfmanagement skills on diabetes outcomes. Several studies have demonstrated increased
frequency of physical activity, diet monitoring, and SMBG (Bielamowicz et al., 1995;
Glasgow et al., 2012; Lorig & Gonzalez, 2000). Others have shown significant decreases
in HgA1c levels, including among low-income and racial and ethnic minority populations
(Gregg et al., 2007; Liebman, Heffernan, & Sarvela, 2007; Rosal et al., 2005; SamuelHodge et al., 2009). Accordingly, patients with diabetes who report higher confidence in
and ability to provide self-care have better clinical and QOL of life measures. In one
study, patients who rated themselves in the 95th percentile for self-management had an
average HbA1c of 7.3 compared to 8.3 for patients rating themselves in the lowest 5th
percentile (Heisler et al., 2003). For low-income, racial and ethnic minority populations,
self-management ability has been found to have a statistically significant association with
diet, exercise, medication adherence, glucose testing and control, and mental health QOL
(Walker et al., 2014). Comparatively, people who use health apps were significantly more
likely to express intentions to improve exercise, weight loss, and fruit/vegetable
consumption than non-app users (Carroll et al., 2017). Diabetes apps may have the
potential to help underserved patients with their self-management behaviors, which in
turn, may lead to better clinical and QOL outcomes.
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CHAPTER 3.

METHODS

This chapter provides a description of the qualitative research methods used in
this study. The statement of purpose given below guides the data collection process
subsequently detailed. Finally, the chapter closes with an overview of the sample
population and site.

Overall Objectives
The underlying reason for this study is to the examine patients’ perception of and
willingness to use mobile health applications in the self-management of their diabetes.
This includes determining their current understanding of mHealth apps and their interest
in using their phones as a healthcare resource. Because health management is such a
personal affair, a qualitative approach best suits the research process.
Rationale for Qualitative Methods
Qualitative research at its core examines how people create and value a social
experience (Denzin & Lincoln, 2008). More, specifically, this refers to any research
about “persons’ lives, lived experiences, behaviors, emotions, and feelings as well as
about organizational functioning, social movements, and cultural phenomena” (Strauss &
Corbin, 1998). Unlike quantitative inquiry, which reduces worldly observations down to
structured numeric values, qualitative research involves a more linguistic approach,
which allows for more flexibility and openness with the data (Corbin & Strauss, 2008).
This type of research focuses on the exploration of multiple perspectives of an
experience. Exploring different patients’ perceptions of mobile health allows a fuller
understanding of the factors and influences that make people open to using their
smartphones for health management. As mobile technology is a newer platform for
healthcare, it is also a newer social experience. Therefore, exploration of mHealth use
lends itself well to qualitative research, in which investigators ask questions with a
beginner’s mindset that is open to viewing everything as if for the first time (Maxwell,
2013).
Qualitative research permits the researcher to study and interpret behavior in
context or natural setting (Denzin & Lincoln, 2008; Merriam & Tisdell, 2016); this
means that people’s families, work, and backgrounds are equally important as the
outcome-of-interest itself. This notion is especially relevant to this study, which sought to
understand patients’ reception of mobile health technology in the setting of limited access
to traditional healthcare providers. The research is about producing thick description
(Geertz, 1973), or a detailed portrayal of the social and cultural relationships that affect
how a person perceives an experience. By fully detailing the context, emotions, and
process of the research, investigators can offer readers a story of what they might expect
if in a similar situation. Thick description “merges the participants’ lived experiences
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with the interpretation of these experiences” (Ponterotto, 2006), allowing the researcher
to share his own theories and ideas about the phenomenon.

Philosophical Construct
For this dissertation, the theoretical framework for the qualitative research is
constructivism. This paradigm asserts that people build meaning in different ways, even
as they experience the same event. Realities are “socially and experientially based” and
“local and specific in nature” but can also have shared elements across groups and
individuals (Guba & Lincoln, 1994). There are several assumptions of constructivism
pertinent to this study: 1. People are constantly engaging with the world and make sense
of it through a lens of culture and previous personal experience; 2. The basic creation of
meaning is always social, arising from interactions with the community at large; 3. Openended, qualitative questions are the best tool to capture how people engage with and then
interpret the world around them (Crotty, 1998). The selection of smartphone apps is not a
one-size-fits-all approach. Each person sees, treats, and lives with diabetes differently.
What one deems as a useful, necessary app function may not hold true for another.
Nonetheless, these individuals have a shared quality of limited primary care access and
therefore might have commonalities across their experiences.
Because all interpretations and results in qualitative research are context-specific,
the investigator holds a central role in the research process. In constructivism, the
interviewer and subject interact in a way so that “findings are literally created as the
investigation proceeds” (Guba & Lincoln, 1994). The researcher thus holds a dual role of
gatherer and interpreter (Stake, 1995). For this study, the gathering consists of culling
information about receptiveness to smartphone apps for diabetes management, and the
interpreting consists of determining these apps usefulness in the context of limited
healthcare access.

Research Design
Phenomenology serves as the primary methodology for this study. This particular
method of inquiry investigates the way people experience and think about the world
around them. It is concerned about uncovering and describing lived experiences and
answers the question “What is this like to experience x?” (Ploeg, 1999; Nieswiadomy,
2007; Laverty, 2008). Phenomenology recognizes that each person perceives and
interacts with the world-at-large differently, and that the world or reality does not exist as
a separate entity from the person (Laverty, 2008). Because this type of inquiry focuses on
how people assign meaning to events lived in their daily existence, phenomenology is
best suited for research that attempts to understand how people perceive, experience, and
react to a certain situation or event. Researchers ask respondents to describe their
experiences through written or oral interviews (Nieswiadomy, 2007). In addition to
offering new insights into how individuals find meaning in a given phenomenon, these
descriptions may include thoughts that are often taken for granted or considered common
sense or uncover any forgotten meanings (Laverty, 2008). Phenomenology is a popular
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research tool in the social and health sciences and can be used to examine a whole host of
unquantifiable health-related situations like insomnia, caregiver frustrations, or
management of chronic pain (Creswell, 2013).
Because phenomenology is a person-centered research approach, it is fitting for
this study. The main research question involves a phenomenon, the use of smartphone
apps for diabetes management, and how people perceive their use. Phenomenology is
also useful to study topics in which there exists little knowledge in the literature. The
application of mobile health to this study’s population of interest, low-income or minority
individuals without access to primary care providers, has not been examined before. To
determine if smartphone apps can be an appropriate resource for these individuals, a
qualitative study is necessary to gauge what value this population would assign to such
apps and how they would use them. A well-executed phenomenological approach
eliminates any taken-for-granted assumptions or preformed opinions about how mobile
health would benefit this resource-limited group and would instead offer valuable insight
into what motivates these individuals to use an app and how they would incorporate the
app into their daily health management. Results from this study also have real-world
applicability since information collected highlights the types of mobile apps individuals
would seek on their own, instead of information about an app which researchers preselected for the individuals to use.
Specifically, this study utilized interpretative phenomenological analysis (IPA) to
investigate how people make sense of using smartphone apps for diabetes selfmanagement. IPA assumes that every person is self-interpreting the world around him
(Smith, Flowers, & Larkin, 2009). This means that each person sees life through a lenses
made of familial history, previous experience, current knowledge, religious and cultural
customs and beliefs, and geographical context. Therefore, two people who experience the
same event may not see or remember the same things. IPA, therefore, tries to make sense
of what an experience is like from each individual’s perspective. IPA recognizes that both
person and context have equal importance in living a phenomenon (Smith, Flowers, &
Larkin, 2009; Pietkiewicz & Smith, 2014). This approach was particularly suitable to this
research question, which seeks to understand how medically underserved patients with
diabetes (presentation of a particular context) assign meaning (personal interpretation) to
the use of smartphone health apps (shared phenomenon). Consistent with IPA, this study
did not seek to test a hypothesis but rather the generation of codes from gathered data.
Rich, descriptive accounts were collected from patients with diabetes about their
experiences with smartphone apps and then each and every account was reviewed in their
unique contexts before making any generalized assessments. Data analysis in IPA is a
distinguishing feature. It is what is termed double hermeneutic, or double interpretative
(Pietkiewicz & Smith, 2014). First, the participants made meaning of the event, the use of
smartphone apps. Then the researcher tried to make sense of how the participants
interpret their own experiences. In coding the data, recurring patterns or themes would
emerge in the text (Pietkiewicz & Smith, 2014). These themes and superordinate themes
are likely to indicate what matters to the patients and what would influence them the most
to seek out and use mobile health.
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Interview Process
The personal interview served as the vehicle of choice for data collection. These
interviews are designed to capture “the meanings that life experiences hold for the
interviewees” (DiCiccio-Bloom & Crabtree, 2006). Because management of a chronic
condition like diabetes involves a variety of tasks that must be individualized to the
patient, each person’s experience with the disease state is unique. No two patients have
the same home and social environment either. Therefore, the decisions one patient makes
about self-care differs from other patients. One-on-one interviews are a suitable way to
chronicle such personal accounts. They also offer the advantage of revealing any issues
or concerns patients might have with mobile health that the researcher would not have
considered (Pope, van Royen, & Baker, 2002).
This study used semi-structured interviews. These types of interviews are the
preferred way of gathering data for IPA analysis (Smith & Osborn, 2008). Each
encounter starts with a predetermined question set but allow for digression from that
question list to explore topics that emerge during the interviewer/interviewee exchange
(DiCiccio-Bloom & Crabtree, 2006). This type of interview format is appropriate when
trying to cover specific topics in a certain order and when only having one chance to
interview a participant (Bernard, 2011). Moreover, the semi-structured interview allows
for probing questions, which are open-ended general questions seeking information on a
topic, as well as follow-up questions, which allow for further response or clarification on
a topic (Kvale, 1996). Veering away from a regimented list of questions allows the
researcher to elicit a more fruitful response from the participant by following his
knowledge and interests. This allows the interviewer to “facilitate and guide, rather than
dictate exactly what will happen during the encounter” (Smith & Osborn, 2008). Even
silence on the part of the interviewer can act as a tool to encourage spontaneous
statements from the subject (Kvale, 1996). The interview questions for this study appear
in Appendix A. The interview process, adapted from McNamara’s steps to staging the
interview follows the outline in Figure 3-1 (McNamara, 2006).

Research Site
Methodist South is a 156 bed hospital with a 24 hour emergency department (ED)
located in South Memphis, TN (Methodist Le Bonheur Healthcare, 2015). While the
Methodist Le Bonheur healthcare system has several other hospitals in the greater
Memphis area, this particular location was most appropriate. This study sought research
subjects with both limited access to primary care providers and ready access to a hospital
ED. The patient populations serviced by Methodist South were most likely to represent
these characteristics. Located in Whitehaven, a neighborhood of South Memphis, this
hospital covers an area that demonstrates characteristics related to an underserved health
population. This community has a predominant minority residency of African Americans
(92%) and Hispanics (3%) (U.S. Census Bureau, 2016). The average Whitehaven
household income is $46,964, which is approximately $8,000 less than the city average
($55,297 for Memphis) and approximately $21,000 less than the county average ($68,182
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Figure 3-1. Stepwise process for conducting personal interviews
Data Source: McNamara C. General guidelines for conducting research interviews
(2006). https://managementhelp.org/businessresearch/interviews.htm (accessed 12 Jun
2015).
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for Shelby County) (U.S. Census Bureau, 2016). Moreover, Whitehaven has few primary
care offices (Figure 3-2), a large portion of which are affiliated with the Methodist South
campus (Research Center of Health Disparities, Equity, & the Exposome, 2017). This is
in great contrast to the density of primary care locations in the city at large (Figure 3-3).
Most importantly, this South Memphis area demonstrates a higher prevalence of diabetes
than the city-at-large. Whitehaven has an average age-adjusted mortality rate of 41.92
deaths per 100,000 people (Figure 3-4) vs. 28.9 for all of Shelby County (Figure 3-5)
(Research Center of Health Disparities, Equity, & the Exposome, 2017).

Protection of Human Subjects
The University of Tennessee Health Science Center (UTHSC) Institutional
Review Board (IRB) provided approval for this study (Appendix B) and related selection
procedures to recruit adults with diabetes for personal interviews. Through Cooperative
Agreements/IRB Authorization Agreements, the Methodist Healthcare-Memphis
Hospitals also provided institutional approval for participant recruitment from Methodist
South Hospital. The UTHSC IRB standard operation procedures (2016) notes the
necessity of obtaining informed consent from all study participants prior to the start of all
interviews. Before each interview, the researcher provided a consent form (Appendix C)
and obtained verbal approval from every participant. Interviewees could refuse to answer
any question they did not wish to address. They were also able to withdraw consent at
any point during the study without consequences.

Participant Criteria
While the literature does not offer an exact number of personal interviews to
conduct, data saturation is key. This means that if after developing themes from
previously collected interviews, the researcher feels that the data from the next few
interviews fall within these existing themes, then the study has reached data adequacy, or
saturation (Morse, 1995). For phenomenological studies, several authors (Morse, 1994;
Creswell, 2013) recommend a sample size of between 5 and 15 interviews; although,
there are no official guidelines for the a priori estimation of interview numbers needed for
saturation (Morse, 1995). IPA echoes this call for small sample sizes with previously
published IPA literature featuring sample sizes ranging from 1 to 15 or more subjects
(Smith & Osborn, 2008). More emphasis should fall on obtaining thick, rich description
than on the total amount of interviews obtained. For IPA especially, if the sample size
were too large, the researchers might become “overwhelmed by the vast amount of data
generated by a qualitative study and are not able to produce a sufficiently penetrating
analysis” (Smith & Osborn, 2008).
This study employed purposeful sampling (Patton, 2002) in the selection of
patients for personal interviews. Purposeful sampling involves selecting for intensity:
picking individuals based on certain characteristics that would provide greater depth to
the data collected (Patton, 2002). Purposeful sampling also produces a cohesive study
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Figure 3-2. Locations of primary care offices around the Whitehaven, TN, area
Notes: The red dots indicate locations of primary care offices. The light blue dot is the location of Methodist South hospital, around
which are clustered several offices.
Reprinted with permission. Research Center on Health Disparities, Equity, & the Exposome. Interactive map of health equity in
Memphis, Tennessee: Health data (2017). http://www.immemphis.com/health-data (accessed 11 Mar 2017).
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Figure 3-3. Locations of primary care offices in the greater Memphis, TN, area
Notes: The red dots indicate locations of primary care offices. The light blue dots indicate locations of hospitals.
Reprinted with permission. Research Center on Health Disparities, Equity, & the Exposome. Interactive map of health equity in
Memphis, Tennessee: Health data (2017). http://www.immemphis.com/health-data (accessed 11 Mar 2017)
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Figure 3-4. Age-adjusted diabetes mortality rates for the Whitehaven, TN, area
Note: The light blue dot represents Methodist South hospital.
Reprinted with permission. Research Center on Health Disparities, Equity, & the
Exposome. Interactive map of health equity in Memphis, Tennessee: Health data (2017).
http://www.immemphis.com/health-data (accessed 11 Mar 2017).
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Figure 3-5. Age-adjusted diabetes mortality rates for the greater Memphis, TN,
area
Note: The light blue dots represents Memphis-area hospitals.
Reprinted with permission. Research Center on Health Disparities, Equity, & the
Exposome. Interactive map of health equity in Memphis, Tennessee: Health data (2017).
http://www.immemphis.com/health-data (accessed 11 Mar 2017).
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population. The more cohesive a sample, the faster data saturation occurs (Morse, 1995).
Selected participants then provide information-rich details about the phenomenon of
interest.
Inclusion criteria were as follows: 1. age ≥ 18 years with diagnosed type 1 or 2
diabetes; 2. ownership of or ability to have access to a smartphone that is able to
download and open apps (self-reported); 3. limited or no access to a regular primary care
provider (self-reported); 4. recent ED visit for a diabetes-related incident. Exclusion
criteria included: 1. patients with diabetes hospitalized without an ED admission; 2.
diagnosis of drug- or chemical-induced or gestational diabetes; 3. patients participating in
other studies related to diabetes treatment and coaching. Appendix D (Tables D-1
through D-4) lists the International Classification of Diseases (ICD) codes used to
identify qualifying diabetes-related encounters from patient charts.

Recruitment Process
Both an emergency department pharmacist and a transitions of care clinical
pharmacist at Methodist South worked to identify potential participants. The ED
pharmacist began the screening process by reviewing the patient chart for the reason for
admission. Then she confirmed the patient’s age and that the patient has a qualifying
diabetes diagnosis through the History and Physical Examination notes and/or an
appropriate ICD-9 or ICD-10 code in the patient’s historical conditions summary. After
confirming both a diabetes-related reason for admission to the emergency room and a
documented diabetes diagnosis, the emergency room pharmacist passed the patient’s
information on to the transitions of care pharmacist. This second pharmacist then went to
speak with the patient. She confirmed with the patient their reason for coming to the
hospital and their diabetes diagnosis. She then provided an overview of the study and
asked if the patient had a regular primary care physician. If the patient expressed interest
in participating in the study, the pharmacist would verify the contact phone number for
the patient to pass on to the study investigator.
Patients who expressed interested in the study then received a phone call about
participation detailing the researcher’s identity, study purpose, and methods. The
investigator would reaffirm the patient’s interest in participating in a face-to-face
interview. During the call, the researcher and patient would arrange a time to meet. The
availability of times for both participant and researcher to meet drove the decision for
interview selection. Each participant provided one interview. All interviews were held
on-site in a private conference room at Methodist South.

Patient Selection Process
The recruitment process took place between May 2017 and February 2018. The
ED pharmacist and transitions of care pharmacist together determined that a total of 34
patients met the eligibility criteria for the study. From these patients, the investigator was
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able to schedule an interview with 23 of them. Of this group, the investigator successfully
met and interviewed 15 patients. Figure 3-6 summarizes the selection process.

Data Collection and Analysis
Data collection in phenomenological research involves gathering deep, rich
information from subjects. Important to this process is bracketing. This is when the
researcher first identifies what he expects to discover or what he believes or feels about
the phenomenon; then he deliberately sets aside, or brackets, these preconceived opinions
and ideas in order to produced unbiased data (Strauss & Corbin, 1998; Corbin & Strauss,
2008).
When the researcher sets aside his own thoughts, it is possible to view the
experience from the perspective of the person who lived it, and the researcher himself
remains open to the meaning each individual assigns to the phenomenon. The data
collection process itself involves allowing the participants to provide a full description of
their experience without any leading or coloring from the researcher (Denzin & Lincoln,
2008). A full description may involve any opinions, feelings, images, memories, or
sensations.
Analysis in qualitative research is the process of creating meaning. Because this
involves a continuous exchange between data collection and analysis, data analysis began
as soon as the first interview concluded (Strauss & Corbin, 1998). The identification of
patterns and themes with the first few interviews helps facilitate further data collection
(Strauss & Corbin, 1998). While the literature agrees that there exists no singular
approach for qualitative data analysis, there are common overarching steps to the process.
The first involves familiarization, or becoming intimately acquainted with the data (Pope,
van Royen, & Baker, 2002; Esterberg, 2002; Creswell, 2009). To do this, the researcher
must first organize the data to prepare it for analysis; this involved repeated listening to
interview tapes and immediate transcription of the audio data. Then the researcher read
through the transcribed interviews several times to become fully immersed in and
familiar with the data (Smith & Osborn, 2008). From these close readings and
familiarization, the researcher could then begin identifying themes and patterns. For this
study, the researcher broke the transcribed data into segments and then organized the
sentence/phrase segments into categories. The researcher then titled each category based
on what the text data said. The next step in this coding process was to build emerging
themes from the categories and data clusters identified. For this step, the researcher
grouped similar or related categories together to identify an emerging theme or
descriptor; the researcher rearranged the clusters of text to produce narrative passages
that supported the themes into which they fell (Pope, van Royen, & Baker 2000;
Creswell, 2009).
The final step to the data analysis process involves interpreting the meaning of the
data (Creswell, 2009). Interpretative phenomenological analysis studies like this one
involve drawing themes and understandings from close analysis of lengthy individual
transcripts (Smith & Osborn, 2008). For this study, this meant discovering how each
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Figure 3-6.

Participant selection process
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participant’s story contributes to understanding how patients assign worth and
significance to smartphone apps for diabetes management. Important to this final step is
accurately conveying participants’ perceptions of their experiences. The analysis process
for phenomenological data is unique in that it is not hypothesis driven. Instead, the data
itself drives the analysis. Readings and review of collected data lead to the emergence of
patterns, which can then be used to code further collected data. Usually, the process first
begins with searching for significant statements that then build into clusters of meaning
and broader themes to describe the experience. From this, the researcher is able to
determine the essence of the phenomenon (Smith, Flowers, & Larkin, 2009). Put another
way, the data allows the researcher to build underlying structure common to the
experience.
Establishing Trustworthiness of Findings
As with quantitative research, where internal and external validity are crucial to
establishing if the research findings accurately reflect what the study observed and if
those findings can be generalized outside the study, qualitative research uses measures of
trustworthiness. Lincoln and Guba noted four criteria for establishing trustworthiness and
goodness of results obtained from a qualitative study: credibility, transferability,
dependability, and confirmability (1985). This study employed several techniques to
establish each of the four aforementioned criteria and overall trustworthiness of the
gathered results.
The first of the criteria, credibility, refers to the confidence in the results
reflecting what the phenomenon the researchers intended to study (Lincoln & Guba,
1985). There were several ways in which this study sought to confirm credibility. Using a
research method that is well-established in the literature ensured that the correct
procedures were used to gather and analyze data (Graneheim & Lundman, 2004). As
previously mentioned, the use of semi-structured interviews to gather data on patients’
willingness to use mobile apps is appropriate for phenomenology research. Additionally,
the data analysis outlined aligns with methods widely employed by qualitative
researchers to develop codes and themes. Establishing trust with participants plays a large
role in the collection of accurate data (Cresswell, 2015). To build trust in this study, the
researcher only recruited participants who showed interested in taking part, notified
subjects at both the start and end of the interview process that they were free to withdraw
at any time without penalty, and de-identified any personal information associated with
the interviews. Before the start of each interview, the researcher emphasized that there
were no right answers to the questions asked and no time limit for each answer,
encouraging participants to contribute talk and ideas about their knowledge of and
attitudes toward mobile health technology. Verifying accurate transcription through
member checks and peer review is also essential to establishing credibility (Lincoln &
Guba, 1985). For member checks, the researcher would summarize at the end of each
interview the stories or information the participant provided and ask the participant if that
was a correct representation of what he or she meant to say (Creswell, 2015). In addition,
a faculty member uninvolved in the interview process reviewed the transcribed dialogue
to verify correct transcription from audio to text. A faculty cohort, either familiar with the
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IPA research process or with the topic of diabetes self-management, also reviewed the
codes and categories created in NVivo to verify that any documented emerging theories
or ideas had support from the gathered dialogue.
The next criterion, transferability, refers to how a study’s findings may apply to
other settings (Lincoln & Guba, 1985). In order for others to see if they can relate this
study’s results to a similar situation, the researcher included relevant contextual
information about the study group, including the research site, the population the hospital
serves, and the criteria for study inclusion. The data itself also contains thick description
(Geertz, 1973) of the subjects’ current knowledge of and attitudes towards diabetesrelated mobile health. Thus, future readers can review the contextual information to
determine if their situation has any parallels to this study. The inclusion of details from
gathered interviews in the results section below also provides “an element of realism”
(Creswell, 2015). The thick descriptions provided allow readers to understand fully the
phenomenon of interest for this study and draw any comparisons with what they see
emerging in their situation.
Dependability demonstrates consistent results (Lincoln & Guba, 1985). This
means that if another investigator were to repeat the research with the same methods,
participants, and context, he would obtain similar results (Elo et al., 2014). To some
extent, duplication of results is impractical because context is ever-changing. The
participants interviewed for this study may have gained additional knowledge about
smartphone apps for diabetes or have changes in their condition or socioeconomic status
that may alter their answers if interviewed again. Lincoln and Guba assert that credibility
and dependability are closely linked in that steps taken to demonstrate credibility may
also ensure dependability (1985). Further measures this study took to address
dependability included a faculty review of the research design used and its applicability
to the research question, a step by step summary below of the data collection and analysis
process, and a description of the participant selection criteria and operational details of
how the researcher set up and structured the interviews. This transparency in the entire
work process enables a future investigator to understand the effectiveness of the methods
used and to replicate the study.
Lastly, confirmability addresses the researcher’s ability to produce objective
findings, results that are not biased by the researcher’s own preferences, biases, or
motivations (Lincoln & Guba, 1985). To bolster credibility, the researcher acknowledged
her own conceptual lens. Termed reflexivity, this is a process by which the researcher
performs a self-assessment of his or her own preconceptions regarding the study and how
this might shape the research process (Malterud, 2001). For this study, the researcher
accomplished this by keeping personal journal notes of how her thoughts and beliefs
impacted methodological decisions, descriptions of the interview setting, and her
subjective thoughts on her relationship with the interviewees (Korstjens & Moser, 2018).
An example of methodological decision-making noted with reflexive journaling was the
researcher recognizing a preconception that this underserved population might be
sensitive about their lower income, especially when interacting with an interviewer who
was pursuing higher education. Therefore, the researcher decided not to structure any
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interview questions with exact income figures or ranges in the hopes that interviewees
would feel more comfortable and would then open up more about their home experiences
with diabetes. Another example would be the researcher’s decision-making process
regarding the interview location. In journaling, the researcher noted more feelings of
comfort and familiarity with the UTHSC campus and the conference rooms available
there. The study participants, however, might not have ever visited the campus or knew
how to get there from their homes. Despite this personal preference for the academic
campus over the hospital site, the researcher chose to conduct the interviews at Methodist
South, reasoning that the participants’ comfort should take precedence to encourage
honest, more fruitful interview responses. In addition to reflexive journaling,
acknowledging the shortcomings of the study’s design and any potential effects can help
establish confirmability (Shenton, 2004). A discussion of this study’s various limitations
and their potential impact on the results appears in the final chapter.
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CHAPTER 4.

RESULTS

This chapter details the findings from the qualitative interviews in terms of the
study objectives outlined in the previous chapters. The results present several overarching
themes drawn from the personal interviews that address the research questions posed
previously.

Research Objectives
The purpose of this study was to gauge patients’ perception of and willingness to
use mobile health applications in management of their diabetes at home. This involved
first gathering an understanding of patients’ knowledge about the disease and current
self-management strategies. Then the interviews also gathered information about
patients’ current knowledge about smartphones and health-related apps to address the
following objectives and sub-questions:
1. Determine what patients are currently doing at home to manage their diabetes.
a. What habits or routines have they developed regarding their diabetes?
b. What do patients identify as challenges or struggles with managing their diabetes at
home?
2. Explore the attitudes toward and interest in the use of mobile health technology in an
underserved population.
a. What do patients know about apps for diabetes?
b. How confident or comfortable are patients with using smartphones and mHealth?
c. How do patients feel about using their smartphones on a routine basis to monitor
their diet, exercise, medications, and blood glucose?
3. Assess patients’ willingness to download and continue using a health app on their
smartphones.
a. What app functions do patients have the most interest in using?
b. Would patients be willing to pay for an app download?
c. How frequently would patients continue to use mobile health apps?
d. What would stop patients from downloading or continuing to use an app?

Overall Themes
The data from all the interviews yielded 11 clusters, each highlighting a
component of the patient experience, which supported 5 overall themes (Table 4-1).
Additionally, 4 of the 11 clusters were further divided into subclusters, which
characterized smaller but distinct components within each cluster. Of these themes, 2
related back to diabetes self-management, and the other 3 themes pertained to
smartphone app use and mHealth. Table 4-1 shows a summary of the data groupings.
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Table 4-1.
Overall
domain
Diabetes
selfmanagement

Themes and supporting clusters derived from interviews
Theme
Diabetes as a chronic
condition requires
active self-management
for successful control.

Supporting
clusters
-diabetes
management

Subclusters
-glucose levels
-complications/comorbidities
-lifestyle management
-medications
-blood sugar monitoring

-challenges to
management
-confidence about
diabetes

Smartphone
app use

Patients often cited
social support, written
materials, and the
internet as meaningful
resources.

-previous or
current phone use

Despite limited
knowledge about
health apps and varying
phone use patterns,
patients were all
willing to try at least
one diabetes-related
app.

-comfort using
smartphones

Apps functions should
be individualized to
meet each patient’s
needs for maximum
benefit.

-app functions
interest

Barriers to app use
were varied but
commonly included
knowledge and
technological
challenges and security
issues.

-barriers to app
use

-resources and
social support

-willingness to
use health apps
-previous or
current phone use
-knowledge about
apps

-challenges to
management

-comfort using
smartphones
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-high
-low

-friends and family
-paper materials
-classes

-number
-payment

Listed in detail below are each of the 5 themes gathered from all 15 personal interviews.
For each theme, information from relevant supporting clusters is presented. Direct
interview quotes, edited only for grammatical clarity and to maintain patient anonymity,
are also used to highlight key points and illustrate personal viewpoints. Although each
theme is listed with a corresponding number, this is simply for convenience when
referencing back a certain theme and does not indicate any form of hierarchy.

Theme 1: Diabetes as a Chronic Condition Requires Active Engagement on the Part
of the Patient for Successful Management
Active Participation. All patients interviewed recognized the importance of
active participation on their part in managing their diabetes. This meant that the patients
knew that their eating and exercise habits, their vigilance in taking their daily
medications, and their overall attitudes towards their health played a significant role in
controlling their blood glucose. Patients also knew that they could not solely rely on
doctors to change their diabetes outcomes. For instance, Participant A shared about his
current plans to include more walking in his daily routine and his recent struggles with
his constant junk food cravings. He states that “I know if I’d’ve keep up, kept going the
way I was, I probably wouldn’t’ve made 50.” Interviewees acknowledged that successful
diabetes control is a proactive process, not merely just reacting to when blood sugars
approach high or low outliers. Participant O spoke about how in his earlier years, he
believed that he had successfully cured himself with healthier lifestyle choices. As soon
as he reverted back to his normal routine, he noticed a corresponding deterioration in his
health:
“Uh, when I first found out I was, I was more shocked than anything because I
was runnin’ a mile a day. I was in college. I was physically fit. Doin’ what I was
supposed to do. So what I did was I started, I started eatin’ like they told me to
eat. Cut back on some of the stuff, but it was really, really hard. And then I went
to the doctor, and they told me that I didn’t have it anymore. They said I had the
honeymoon effect. And I let myself go. And when I let myself go, that’s when I
started havin’ all the other complications and problems.”
Additionally, Participant E expressed how difficult glucose management could be
sometimes, noting that successful control requires time and effort on the individual:
“Yeah, it’s not good shape because you get sugar in your blood. It’s hard to take it
out from you. Yeah, it’s not easy. Yeah, and it’s hard to control it all the time
because people be running around everywhere. It’s hard to just stay, sit, and
controlling this, uh, uh, this sick. It’s hard to uh, it’s hard little bit to fight it.
Yeah, it’d be somebody like say you have time, you have a lot of resources, you
have, uh, experience, you can deal with it, but however it’s still not easy with
diabetes.”
Another key viewpoint that emerged from the interviews is how these patients
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equated healthy as being not sick, instead of being well. As defined by the World Health
Organization (WHO), the traditional meaning of health is “a state of complete physical,
mental, and social well-being and not merely the absence of disease or infirmity” (1948).
The WHO goes on to further to explain that “health is a positive concept emphasizing
social and personal resources, as well as physical capacities” (1986). Yet, for many
interviewees, they viewed health not as a positive state of being. Instead, they saw good
health as the lack of problems in their daily lives. They essentially defined good health as
not having bad health. In the words of one interviewee: “So, in my eyes, as long as you
weren’t sick, you were ok. When I say sick, I mean down and couldn’t get up” [personal
communication by Participant B]. For many of the patients interviewed, this meant they
defined good health as the absence of comorbidities, acute illness, or hospital admissions
versus the presence of wellbeing in their daily home lives. Participant B continued: “To
me there’s no perfect when you’re dealin’ with diabetes. You know, you just gotta take it
one day at a time.”
Of interest to note with a few of the individuals with older, longstanding diabetes
diagnoses is the sense of regret they feel about their lifestyle habits when they were
younger and newly diagnosed. These patients talked about how, initially, they lacked an
understanding of diabetes as a lifelong condition. Consequently, they spent much of their
earlier years with the mindset that the health of their youth could trump their poor eating
habits and missed medications. By not adequately managing their diabetes in those early
stages, these patients now have to live with the complications that come with more severe
disease progression. For instance, Participant L lamented:
“Well, it started workin’ on my organs, my eyesight, my kidneys, and, uh, I get
neuropathy now. So that’s it. Well, I wasn’t taking care of myself at the
beginning. And now tryin’ to do everything right and stuff. And it’s just, I guess
it’s just too late to just workin’ on it now. And I’ll tell anybody with diabetes: Be
serious with it, you know. You can control it and not let it control you. […]I was,
guess I was young then and didn’t wanna do right by it. But I see now if you right
by it, you can, you can be happy with it.”
Participant B expressed a similar sentiment: “Now I’m older, and I’m receiving the
repercussions from me not taking care of it when I was younger. So, kinda karma I
guess.”
Goal Setting and Monitoring. In addition to speaking about the importance of
self-engagement, several participants also noted that they had goals for their blood sugar.
These patients indicated that they checked their glucose on a daily basis and are aware of
what constitutes a “good” or “bad” reading.
Patients also touched upon how besides using a meter to measure a numerical
reading, they could tell when their glucose might be outside the normal range. Several
patients described symptoms of feeling unwell. For one participant, elevated blood sugars
cause changes in mood, leading to short temperedness and peevishness: “Because if, if it
go too high, it’ll have me real irritable, you know. The least little thing you say, it’ll make
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me go off. You know, and I don’t have no reason to be going off, and it’d be doin’ certain
things in my system. It, uh, just ain’t good. Diabetes ain’t good for me. […]Mhmm, and it
has me real nauseated at times. It’ll have me to throw up at times.” Another interviewee,
a newly diagnosed patient, described a constellation of physical symptoms that let her
know to seek medical attention. These symptoms ranged from a loss of taste to profuse
night sweats. Finally, she stated, “I been havin’ symptoms, but I didn’t pay ‘em any
attention. I knew something was wrong, but I just never could put my finger on it. Then,
uh, when my sight started going blurry, […] and I, uh, that’s when I came to the
emergency room, and I found out I was diabetic [personal communication by Participant
F].” Other interviewees also spoke of similar mental and physicals signs they would
watch for to indicate fluctuating sugar levels. For example. Participant O detailed both
physical and mental changes that come with high and low glucose extremes:
“Uh, you can tell when your sugar’s low because it feel like you either about to
faint or you feel like something’s, like a whole, whole bunch of pressure on you.
Like somebody’s just sittin’ on you or weighing you down. Uh, another thing is
you start to sweat. Uh, you’ll either, you can have cold chills. Now when you’re
high, uh, you know that for a fact because you, you’ll be runnin’ back and forth to
the bathroom all the time. Have to urinate just constantly [snaps fingers for
emphasize], constantly, constantly tryin’ to get that sugar out your body. Uh, you,
you can get dizzy. Lightheaded. Um, or your heart could start to race. Or you’ll
be, you’ll be really fatigued. You’ll be tired. You be wantin’ to sit down. That
works both ways when it’s high, and it’s low. You be really fatigued. Uh, you
don’t have any motivation. And I’ll tell you something else too with the diabetes,
it’ll change your mood. Uh, you’ll have mood swings really, really bad. Like
when my sugar is low, I snap out. When my sugar’s high, I snap out. It’s just like
I just change into somebody else.”
Others spoke about having good and bad days based on their glucose levels:
“Like when I’m doin’ good, I feel better like my day goes by differently than if
it’s doin’ wrong. Then I’m using the bathroom frequently and kinda lightheaded,
you know, just little signs. Not normal, and I don’t know like, it’s like too high
[personal communication by Participant J].”
Patients were quick to point out the importance of medication adherence. Patients
also knew that lifestyle management including diet and exercise plays a role in disease
progression. Knowledge and confidence in management were linked with more
knowledgeable patients often citing higher confidence level. Patients also spoke about
blood sugar monitoring and possibly adjusting their diet/medications based on certain
readings. Patients with diabetes-related complications spoke of wishing for better control
and management in their earlier years. Some stated that successful management can be
costly.
Diet and Exercise. Every patient interviewed indicated awareness that simply
taking medications for their diabetes was not enough to manage blood sugar.
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Interviewees recognized that keeping up healthy daily diet and exercise habits directly
impacted their diabetes. For Participant D, her previously poor diet was what precipitated
her latest ED admission and diabetes diagnosis. She explained, “It just flared up just like
that. So I was drankin’ a whole lot of sweet drinks, and, you know helpin’, I was helpin’
it along to tell the truth about it.” Prior to her diagnosis, Participant D confessed that she
was eating “anythang, I thought I could eat anythang I wanted like I was doin’, you
know. You know, mostly sweets. You know, I used to like, I like sweets […] You know,
a whole lot of donuts, cakes, and stuff like that, you know.” After her glucose climbed to
over five hundred and led to her emergency room visit, she began “eatin’ the proper
food,” making changes to her diet to incorporate more salads.

Theme 2: Patients Often Cited Social Support, Written Material, and the Internet as
Meaningful Resources They Used for Their Diabetes
All patients interviewed touched upon the importance of having someone to talk
to about their diabetes. The majority of patients spoke of another living family member
who also had diabetes. Additionally, several patients listed multiple family members,
both living and deceased, who were also diagnosed with the chronic condition. Patients
often used family history as a marker of disease progression and an example of what
could happen with poor self-management. For example, some interviewees spoke at
length about their extensive family history of diabetes and the complications of disease
progression in close kin:
“Well, for one, my mom, she was diabetic, and she had a lot [stretches word out]
of problems: amputations, uh, renal failure. So I saw her go through a lot dealing
with diabetes. So that kinda put me on the straight and narrow, seeing what she
went through. And, there were, she had 8, 7 siblings, and everybody was diabetic.
All of ‘em. So, [small hmph noise] I kinda saw what my family went through with
dealin’ with it. So thank god I hadn’t had any serious issues, which if I had’ve
kept goin’ like I was, I probably would. But I’m gettin’ better at it. You know, I
didn’t take it real, even though I saw what my mom went through, I still didn’t
take it as serious as I should have. But now, now I do. [personal communication
by Participant A]”
“They never told me to watch out for it, but they always, always, you know, they
always told me how bad, and I always and I saw what diabetes, you know, did to
‘em. I saw what it did to my grandmother. I saw what it did to my mom. My mom
just passed little over a year ago. So I know, I just know about what diabetes
would do. […] For my family, you know lookin’ at them and seein’ what, you
know. Some of ‘em got some of they, uh, fingers cut off, some of they toes cut
off, you know, because of diabetes. Yeah, I, I, I know about diabetes. [personal
communication by Participant F]”
Participant J also noted an extensive family history of diabetes: “My dad has it. My
grandmamma had it. Well, it’s like the majority of my family.” Participant L also spoke
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at length on her family history: “Two of my sisters have diabetes. I have a nephew and
brother. It’s, it’s run deep in my family. Heavy. My mother had it and, uh, aunt, aunts and
uncles had it.” She also noted that they had all passed away. Her one surviving relative, a
brother, who also has diabetes, has a sore on his leg that will not heal and “hurts so bad
when he try to walk on it.”
Other interviewees also mentioned several family members with diabetes who
could provide guidance and advice. Examples include:
“My mom, she died three years ago. So she was a big help to me because, like I
said, she was in the medical field, AND she was diabetic. […] So any problems I
had, she had the answer, you know. […] So, when I lost her, I lost a lot. So I have
to rely on my aunt now. But as far as like callin’ doctors or something, I don’t you
know, I have none. She pretty much helps me out. [personal communication by
Participant A]”
“Yes, my sister and my brother [have diabetes]. […] I just got to talk to my sister
about it. She said you need to try to, try to get it to come down ‘cuz you would
end up with amputation or death. [personal communication by Participant H]”
“Um, my brother. My sister. Um, they is, they is the ones who educated me and
told me some proper procedures. And my dad, he had it. [personal communication
by Participant I]”
“Um, I talk, I actually talk to my grandmother. She’s more, me and her more, um,
close. We’ll talk about it ‘cuz she’ll ask me sometimes, “[patient’s name
redacted] what do you do when your sugar drop low?” And I tell her I try to, um,
[…] to get a small box of juice or some crackers whatnot. Don’t get it too, don’t
get too low ‘cuz I had to come to the hospital. [personal communication by
Participant K]”
Knowledge and empathy play an important role in defining the relationship
between the patient and friends/family concerning diabetes. Many participants talked
about being able to turn to various friends and family members who also had diabetes to
talk about experiences with the disease. Participant O expressed, “I got friends that’s
diabetics. So we watch out for each other.” For some patients, like Participant D with his
sister-in-law, they speak about how meaningful it is to receive advice from a family
member who also have diabetes:
“Yeah, she gave me advice about how she do. She said, you know, don’t do it, gotta
get your own little pace. The way, you know, the way you want it because some days
you wake up feelin’ good, you know; some days you wake up feelin’ bad. Some days
you wake up shakin’ a little bit. Gotta get you a piece of candy. She just, she just
took me through the whole time. She said I need my own little pattern when I wake
up in the mornin’ time, what time do I wanna take it, you know.”
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Participant B spoke of support in a different but equally meaningful manner. He
explained that when he was younger, his mother was not as involved in his life and
health. He moved out of his home at 14 to do what he “wanted to do and all that” and that
he was “kinda on [his] own for the most part and managing.” He described the situation
as “kinda haywire.” Recently, however, his mother finally took an interest in his diabetes,
attending an educational session with him at his local church. He said, “For the first time
since I’ve been diabetic. This is the first, any type of diabetic education she’s ever. […]
So I was glad about that. And it looked like she was payin’ attention. She was taking
notes, and I could tell that a lot of the things that she thought were right, she figured out
that they were wrong. So, it helped.”
Other interviewees expressed how important the support of their spouses is in
their daily lives. Although the spouses themselves do not have diabetes, they are integral
in helping with these patients with their day-to-day at-home management. Examples
include:
Participant G said, “He [referring to her husband] helps me out; he helps me out,
uh, with the food. Sometimes I just can’t, you know, do it.”
Participant L lists, “Lately my husband’s been exercising me around the house.
[…]Matter of fact my husband does it all; he cooks for me. […] Um, he help, he
dresses me. Help me take baths. He combs my hair.”
Participant N proclaimed, “My wife helps me a ton. She stays on me all the time
to, to keep it right. And me and her have been talkin’. She says she’s gonna
tighten up on me when I come home ‘cuz gotta be done. […] she just watches
after me, try to make sure I try to eat right and stuff.”
Patients acknowledged receiving information at discharge but often felt
overwhelmed or detached. When specifically asked about receiving any instruction or
handouts at the end of her hospital stay, Participant G expressed indifference: “They
probably did. I don’t, I ain’t read ‘em, baby. I’ve been throwin’ up and stuff. I dunno,
can’t remember.” Participant E also mentioned receiving a stack of paper at discharge:
“Yeah, they give us papers. They in the car. Yeah, just to eat something, a lot of time
eating vegetables, no eating something like, uh, have so many sugar. Uh, that kind of
education, uh, they give us. A little bit, little bit. […] we look a little bit and put down.”
More proactive patients also attended classes and turned to books/magazines, as
well as looking up information with their phone’s internet. Participant O explained about
going to classes when he was first trying to learn about diabetes:
“I used to go down, and also you can go downtown to, uh, on Eastmoreland. They
have, they, uh, a class down there where it’s like a nurse prac, prac-somethin’. And I
used to go to the classes where they teach you how to carb count and your meals.
And they have those like at Christ Community and different organizations. Just pick
up a sheet and found out where they is, where they at. And I used to attend those.”
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Theme 3: Despite Limited Knowledge about Health Apps and Varying Phone Usage
Patterns, Patients All Indicated a Willingness to Try at Least One Diabetes-related
App
Current Smartphone and App Usage. Smartphone usage varied widely among
the participants from no or past ownership to current ownership. While some like
Participant C owned a smartphone “pretty much since they first came out,” others like
Participant G “never used one before” but her “kids probably got one.” Those currently
without a smartphone indicated that someone within their immediate household owned
one that they could use. Almost all current smartphone owners expressed comfort with
operating their phones. Many expressed positive feelings about their smartphones. They
used their phones multiple times a day as a part of their daily routines and habits, one
interviewee noting that it was “second to nature, havin’ a phone” [personal
communication by Participant B]. Moreover, several patients also expressed ease with
their phones as a multi-functional tool. Beyond making calls, they used their phones
routinely for other functions like texting, listening to and creating music, accessing social
media, watching videos, and searching the internet. These patients considered their
smartphones as an integral resource in supporting their daily lives.
While the majority of patients interviewed either knew nothing about smartphone
mHealth apps or had never used one previously, a few did indicate previous use of a
health app. These apps were mostly related to filling or pricing medications. About 20%
of interviewees stated that they had previously downloaded and used a drug pricing app
to help them “look around for the cheapest” way to fill a prescription, especially when
they “didn’t have insurance” [personal communication by Participant J]. These patients
noted a positive experience with prior health app use. One participant, who had a higher
comfort level with smartphone use, described a previous experience with a blood glucose
app as such: “I used to have this app where you write down your blood sugar, but I, some
kinda way I deleted it. I don’t know why. Um, I’m comfortable in usin’ ‘em. It’s, it’s
actually helpful because it usually remind me: did you take your sugar? Or I usually put
in my text remind me to check my sugar. And I use the bing bing gotta take your sugar.”
[personal communication by Participant K]
Other interviewees spoke of the importance of using their smartphone to go online
to research information about diabetes. Participant C stated, “Uh, I google it and read
pretty much about it.” Some voiced that they turned to the phones whenever they had
questions about their chronic condition. One patient described a need to “googled a lot
[…] whenever I had questions about anything. You know at night, I just googled all the
time” [personal communication by Participant J]. Another turns to Google to “answer
questions and ask […] what are some foods to eat for diabetes concerns” [personal
communication by Participant I]. Moreover, another patient described using mobile sites
like Google and Youtube to see “what’s gonna happen to somebody, uh, when you not
take care of diabetes” and to see “picture of like I don’t wanna end up like that, you
know” [personal communication by Participant K].
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Openness to Diabetes Apps. All patients, despite their varying comfort levels
with using a smartphone, expressed a willingness to try a diabetes health app. Several
interviewees mentioned that they would try apps based on recommendations from friends
or family. For instance, Participant H conveyed interest in installing an app if “family
members tell me about it.” Participant O also stated, “Uh, if I had a friend or someone
that say, ‘Hey I’m doin’ this such and such, and look it’s workin’ for me.’ Then yeah I
would look at it.”
Patients less familiar with smartphones indicated the need for someone at the
hospital or in their immediate family to educate them. Participant H stated that she would
“get my son to come over and set it up for me.” Even Participant G, who had no previous
exposure to smartphones, expressed openness to using an app and that she “would have
somebody show me.” Those not as familiar with the smartphone platform also indicated
their willingness to invest more time, “to put a foot forward,” in becoming acclimated to
their mobile devices, especially if “expectin’ a good turnout” [person communication by
Participant B]. Even though most of these patients knew very little about diabetes apps,
there “ain’t nothin’ wrong with tryin’ somethin’ different once” so that if they do “get it
workin’ right,” they “might like it” [personal communication by Participant D]. Almost
all participants said that they would try to use at least one app daily. Additionally, all but
one indicated a willingness to pay to download an app if they thought it might be
beneficial to their diabetes management.
Almost all interviewees stated that they would be willing to continue using at
least one mHealth app until they either gained perfect health or could not get any benefit
from using an app anymore. Participant I proclaimed simply, “I’m gonna keep on ‘til I
can’t.” He then went on to explain that the only reason he would stop using an app is
“because it’s not, basically just not, um, any kind of positive direction far as helping me”
[personal communication by Participant I]. In fact, Participant B mentioned that success
with an app, as with anything related to diabetes self-management, requires active
participation on the patient. He said, “I just know that you have to be able to go to it and
put the information, be willing to put the information in. That’s the, that’s the other half
of it. You have a responsibility to put the information in.”
Theme 4: App Functions Should Be Individualized to Meet Each Patient’s Needs for
Maximum Benefit
Feedback provided from the interviews supports the idea of tailoring app
downloads to patient need. It is better to suggest one or two apps that solely have one
function vs. a one-size-fits-all multifunction app. Patient interests were varied with a
majority expressing interest in something food or diet-related. Patient often expressed a
need for real-world knowledge, instead of clinical or medical knowledge. They often
spoke of frustrations with healthcare providers using clinical or medical language in their
conversations and not really understanding how to translate this medical advice into their
daily lives. A few patients had already tried a medication pricing app previously and
found it to be useful. Of note, almost all patients expressed the importance of having app
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usage fit into their everyday routine. They stated that they did not want to have to go out
of their way to use an app.
Participants expressed different challenges in their day-to-day diabetes
management. Even when patients spoke about a similar topic, like proper diet, their
struggles with that issue were different. For example, one patient expressed the following
diet-related hardship:
“Well, uh, as far as I can see, it’s like I have to balance. At first, I didn’t worry
about what I bought or what I ate, but now, I have to, uh, you know, buy the
rights things to, uh, eat when I used to just eat whatever I wanted. But I can’t do
that no more. Being on fixed income, uh, I have to just really not, you know, just
spend on, on something that I normally would. I have to just spend my money on
something that’s more healthy, or, you know, it’s, it’s been a challenge especially
since you used to eatin’, you know, whatever you want to. But now you’ve got to
be limited, you know, to what you eat, and it’s been a struggle.” [personal
communication by Participant F]
Another patient, although mentioning the same topic of diet and food, voiced a different
concern:
“Oh man, stayin’ away from sweets. You know, like the holidays, like
Thanksgivin’, they make ‘em peach cobblers and sweet potato pies. It’s hard, and
then when you sittin’ there with all that food […] You know hey I can only have a
certain amount of this food. You know what I’m sayin’? And but you wanna try
everythang. If you try everything, you gotta get real, real small portions, but then
what happen when you get something you really like? Then you eat too much.
You know what I’m sayin’? You overindulge. And then you got the sweet stuff.
You like, “I’m a try a piece of this” or then, then your sugar’s outta whack.”
[personal communication by Participant O]
Even though the patients above relayed food-related challenges, their struggles were
different. While the first patient might appreciate a diabetes-friendly grocery list/budget
tracking app, the second patient might obtain more benefit from a calorie/carb counting
app. Therefore, it is better to suggest one or two apps with functions that meet each
patient’s greatest needs over a one-size-fits-all multifunctional app.
The same theme of individualization arose with interviewees who spoke of
challenges with managing their medications. For Participant K, forgetfulness is constant
issue. She lamented:
“You know, now my medications, it’s a little, it’s a struggle. It is a struggle. Um,
uh, it, it’s a struggle. […] I’m a little clumsy with it. So I may forget. My mind
sometimes forget where I put it, and it makes me go, ‘I know I had it, but where
did I put it at?’ You know what I’m sayin’? And it’s, it’s hard for me to keep up
with it. [personal communication by Participant K]”
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For Participant K, a medication reminder app would provide the best benefit to her daily
diabetes management and help “keep [her] on track” [personal communication]. Whereas
one patient might find great value in an app that reminds him to “do the insulin” on time
[personal communication by Participant J], another proclaims that he “can keep up with
my, you know, what I need to take and when I need to take it. You know, I can pretty
much do that myself” [personal communication by Participant A]. For Participant A,
remembering to take his medications was not a roadblock to his self-management.
Instead, he talked about the hardship of not having health insurance and showed interest
in app that could price medications for him.
“Uh, to be honest, here (pointing to an example picture of drug pricing app) it
tells me about the medication and how much it may cost. (chuckles) Because
that’s one of, that was one of my issues for a while was bein’, was affordin’ the
medicine that I need. […] And that bottle of insulin is three hundred bucks
(punctuating each word deliberately) [personal communication by Participant
A].”
No one app can be used to help all patients with their at-home diabetes management. App
selection must be tailored to each patient’s specific challenges and needs.

Theme 5: Barriers to App Use Were Varied but Commonly Included Knowledge
and Technological Challenges and Security Issues
Many patients stressed the importance of an app as being user-friendly, something
“not hard” or “super complicated” [personal communication by Participant B]. This
meant that they did not want something that required extensive training to use. Those less
comfortable with operating a smartphone expressed hesitance at being able to use an app
effectively. These patients would need for someone, either a hospital provider or a family
member, to guide them through using an app. One of the less technically inclined
interviewees, Participant N, also expressed concern about re-downloading an app used on
a current phone to a new phone: “I can say if it’s somethin’ happened to my phone or
somethin’, where it quit workin’, you know. And I’ve had had that trouble. And I don’t
know if I can transfer this app to another phone, or if I, I have to redo it. I don’t know
how that works.”
Other concerns noted were related to privacy and security. Interviewees expressed
concerns about inputting personal data in an app and theft of that information. Most felt
comfortable in giving up health metrics like weight or blood glucose reading but were
leery about disclosing any financial information. “Cuz I don’t think those, what do they
call them, cyber thieves or whatever, I don’t think they can do a whole lot with my height
and weight information. But bank account information, they can probably do something
with that,” explained Participant A. Those who currently owned a smartphone were more
likely to bring up technological challenges like storage space or frequent need for
updates. They expressed a desire for an app that would run smoothly “on the regular”
without crashing their phones or have “somethin’ happen […] where it quit workin’”
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[personal communication by Participant N]. A couple of patients also brought up fears of
too much spam or viruses.
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CHAPTER 5.

DISCUSSION

Personal interviews from low-income, racial and ethnic minority patients with
diabetes indicated an interest in using smartphone mHealth apps. These patients had
widely different baseline exposure levels with smartphones, ranging from only seeing
those in their immediate household use the phones to consistent, daily use. Nonetheless,
all interviewees stated they were open to using a diabetes-related app. Even those with
very little or no previous exposure to a smartphone voiced a willingness to try at least one
app at home; their interest in seeing if mHealth could benefit their diabetes management
overrode any hesitance over using unfamiliar technology.
Patients mentioned common hurdles related to medication affordability and
adherence, proper diet and exercise, and fluctuating blood glucose management. Thus,
they demonstrated interest in app features related to diet, exercise tracking, and
medication management. This is similar to findings from previous survey questionnaire
studies where patients indicated app preferences for activity tracking, medication
reminders/alarms, carbohydrate counting, and blood glucose tracking (Conway et al.,
2016; Lithgow, Edwards, & Rabi, 2017). Participant struggles, however, were
individualized to their diabetes progression and their current living situation. For
instance, several patients noted struggles with their diets, but they might not benefit from
using the same diet-related app. To provide the greatest benefit to this underserved
population, app selection should be tailored to address each patient’s specific at-home
need.
Participants also expressed varying concerns over app use. These ranged from
user-oriented fears, i.e. inadequate technological knowledge to work an app, to apporiented concerns, i.e. data security or virus attacks. In line with a previous survey study
(Lithgow, Edwards, & Rabi, 2017), the majority of interviewees said that they would be
willing to pay for an app so cost to download would not be a barrier to use.

Study Limitations

Generalizability
Limitations of this study include a potential inability to generalize results beyond
the underserved Memphis population, as patient struggles and experiences may different
in light of other geographic and cultural settings. Future exploratory studies like this one
should be initiated in areas outside the Southeast to capture patient backgrounds,
management challenges, and technological proclivities unique to other underserved
populations. Since the majority of patients interviewed had T2DM, findings from the
study may not be generalizable to patients with T1DM or those with undiagnosed type 1
or 2 diabetes. Moreover, the study results may not apply to apps not readily available to
the public for download, such as apps specifically developed for a hospital electronic
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medical record or a private practice group. Since this was a general exploratory study, no
correlations could be drawn between patient characteristics like disease severity or
duration and interest in certain apps or app functions.

Selection Bias
Selection bias may have also influenced the study’s results. First, the hospital
charts did not routinely collect PCP information. Patients therefore self-reported whether
or not they regularly visited a PCP for their diabetes. The study was then only able to
collect interviews from those who were truthful about this and was not able to gather
information from patients who truly had no PCP but told the screening pharmacist that
they did. The patients who agreed to participate and were able to come to an interview
might have also been more inherently motivated to manage their diabetes and to express a
willingness to try an app. The interviewer worked to established trust with the
participants by clearly outlining before each interaction that there were no right or wrong
answers and that all answers were to remain confidential and anonymous. Nonetheless,
participants could have still felt compelled to please the interviewer by expressing
interest in using an app, even if they truly had no desire to try one. The inclusion criteria
of a diabetes-related ED visit could have also influenced the participants’ responses. With
the shock of a health event fresh in mind, interviewees may have been felt more
compelled to express willingness to use smartphone apps than if they had not experienced
a recent diabetes-related complication.

Future Considerations
An intensive search of the literature revealed no previous qualitative studies about
leveraging smartphone apps to address diabetes-related health disparities. Results from
this study show a potential for mHealth apps to be a valuable resource in an underserved
patient population. Therefore, the findings from this study indicate a need for further
research in engaging vulnerable patient populations with mHealth. This could include
future pilot studies examining clinical effectiveness on blood glucose levels when making
a personalized app selection for patients to use at discharge. Additional studies could
examine the cost effectiveness of having underserved patients use smartphone apps at
home to prevent diabetes-related ED readmissions.

Implications for Discharge Planning
During the interview process, several patients spoke about receiving a stack of
papers related to diabetes education upon the leaving the hospital. They, however, did not
talk about the interaction in a positive or meaningful way. These patients did not speak of
having any significant face-to-face engagement with a health care worker regarding next
steps for at-home self-management upon discharge either. This is a space where
recommendations for app usage may fit. All interviewees from this study expressed
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interest in and openness to using a diabetes smartphone app. Those less technically
inclined, however, voiced concerns about being able to navigate an app without
assistance. Discharge may be a fitting time for a health provider to introduce diabetesrelated apps to patients for future use at home. In order to provide the most benefit to
patients, the discharge provider would need to speak with each patient to discern
challenges and needs for at-home disease management. The provider could then
recommend one or two apps based on the patient’s response. To be most effective,
providers would also need to help patients install the app on their phones, launch the app,
and use the features within the app.
One significant reason that patients who met the inclusion criteria could not
participate in this study was a lack of transportation for a return trip back to the hospital.
This is an example of how resource poor this sample population was. Limited
transportation along with low income and/or lack of health insurance restricts these
patients’ access to traditional healthcare resources like clinics and physician offices. This
is the resource niche that diabetes apps can fill. Unlike their troubles with transportation,
all interviewees in this study indicated either ownership of or proximity to someone with
ownership of a smartphone. Introducing an app to the patients at discharge would provide
them with a low-cost, easily accessible resource that they could turn to on a daily basis at
home. Also, having a healthcare provider offer recommendations and education might
instill trustworthiness in an app. A provider recommendation would offer confidence in
both the app itself as a health tool, as opposed to spam or malicious software, and the
health information offered within the app. This could help address concerns related to
privacy and security that some patients brought up during their interviews.

Training for Healthcare Providers
In order for the discharge process to provide the greatest benefit to these
underserved patients, the healthcare workers involved would first need adequate
education. Healthcare providers themselves would first have to be comfortable with using
smartphones. Initially, providers would need to create a rubric to vet diabetes apps for
accuracy of information, ease of use for their specific patient population, and digital
security. To maximize patient benefit, each healthcare facility should develop its rubric
based on characteristics like literacy level of the patient population they serve. Providers
would then need to familiarize themselves with the apps that scored highest on their
grading scale within each broader category of diabetes management like
glucose/symptom monitoring or diet/carbohydrate counting. Thus, at discharge, providers
would be able to make an informed decision on the best app to recommend each patient
for home use going forward.

Future Cost and Clinical Impact
Once acceptability and openness to diabetes app use has been established, as with
the underserved population in this study, it opens the way to many other future
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considerations for incorporating mHealth into healthcare practice. From a clinical
standpoint, future studies could examine the effect of at-home app use on blood glucose
or HbA1c measurements in low income and racial and ethnic minority patient groups
with diabetes. These studies could compare app vs. no app use over different periods of
time from as short as a month to as long as a year. This could help determine the
minimum amount of time individuals would have to use a diabetes app to start seeing any
health benefits, as well as the frequency with which patients would have to interact with
an app on a daily or weekly basis. Additionally, this would keep people from quitting app
use too early, within a few days or weeks, if there were published results on how long it
could possibly take to notice changes. Study results showing a significant decline in
glucose or HbA1c markers would demonstrate that apps could be a clinically effective
tool for a population that would otherwise struggle to access traditional pathways to
healthcare.
Determination of clinical efficacy would pave the way for further research
regarding the economic impact of diabetes app use. Studies to examine re-hospitalization
or revisits to the ED for diabetes-related episodes could possibly show reduced rates after
the introduction of app use. With a 30-day readmission rate of about 20% for patients
with diabetes (Rubin, 2015), the annual cost of diabetes re-hospitalizations is currently
estimated to be almost $25 billion (Soh et al., 2020). By contrast, the overwhelming
majority of commercially available health apps are free to download; those that require a
purchase to download average about $2 in cost (IQVIA, 2015). Even the prevention of
just a handful of readmissions for a hospital each year through the introduction of app use
at discharge could present possible savings of thousands of dollars. This is an area where
future research could delve into. Studies could look at introducing an app for home use to
known patients with multiple monthly or annual visits to a hospital’s ED for diabetesrelated crises. They could then compare ED visits pre- and post-app introduction to
identify any potential reductions in visit rates and cost savings for the averted
readmissions.
Accordingly, the effectiveness of these cost savings could possibly extend into
changes in insurance reimbursement models. Insurance companies, as the potential
recipients of study findings related to healthcare cost savings, could consider future
payments for care activity related to diabetes app use. This could include anything from
discharge counseling specifically directed towards diabetes app education to outpatient
medication therapy management sessions that incorporate education about using
adherence apps.

Conclusion
Successful long-term management of diabetes depends heavily upon choices and
actions that happen beyond a doctor’s office or hospital. For patients who have limited or
no ability to establish a meaningful relationship with a healthcare provider, management
can prove very challenging. The use of smartphone health apps could potentially address
certain resource limitations for these patients. Results from this study showed that all the
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interviewed patients recognized the importance of their own actions and behaviors on
their diabetes control. While these patients had differing home backgrounds and comfort
levels with smartphone technology, they also all voiced a willingness to use at least one
diabetes-related health app in their daily lives. This openness to mHealth serves as a
foundation for further exploration into the clinical and economic impact that diabetes app
use might have for a traditionally resource-poor patient population.
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APPENDIX A. INTERVIEW GUIDE

Questions Related to General Diabetes Self-Management
1. What do you currently do to manage your diabetes?
2. How confident do you feel about how you manage your diabetes right now?
3. What resources do you currently use to help you manage your diabetes?
4. What is the biggest challenge you face with your diabetes management?
Questions Related to Current Smartphone Use
5. How comfortable are you with using a smartphone?
6. Other than calling, what do you currently use your phone to do? How often do you use
it?
Questions Related to Smartphone App Use
7. What do you know about smartphone apps designed to help you manage your health?
Have you tried one?
8. How do you feel about using a smartphone app to help manage your diabetes?
9. What would be a reason to persuade you to use a health app (i.e. recommendation from
friends/family, saw a commercial, high reviews in the app store from users)?
10. What kind of app features or functions would be most helpful to you?*
11. How often would you be willing to use an app? How many apps would you be willing
to use?
Questions Related to Barriers
12. What concerns do you have about using a smartphone app for your diabetes?
13. What reasons would stop you from using an app?
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*Along with question 10, the interviewer also provided some sample images of
smartphone apps as shown below.
1.

2.

3.

Reprinted with permission. 1. GoodRx Inc. GoodRx mobile apps (2011).
https://www.goodrx.com/mobile (accessed 3 Nov 2015). 2. Medisafe Project Ltd.
Medisafe app (2015). https://www.medisafeapp.com (accessed 3 Nov 2015). 3.
MyNetDiary Inc. MyNetDiary (2015). https://www.mynetdiary.com (accessed 3 Nov
2015).
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4.

5.

6.

Reprinted with permission. 4. mySugr. mySugr app (2015). https://www.mysugr.com/enus/diabetes-app (accessed 3 Nov 2015). 5. Helparound. Helparound app (2015).
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APPENDIX B. UTHSC IRB STUDY APPROVAL LETTER
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APPENDIX C. STUDY CONSENT FORM
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APPENDIX D. ICD-9 AND ICD-10 CODES FOR STUDY PARTICIPATION

Table D-1.
ICD-9 code
250.00
250.01
250.02
250.03
250.10
250.11
250.12
250.13
250.20
250.21
250.22
250.23
250.30
250.31
250.32
250.33
250.40
250.41
250.42
250.43
250.50
250.51
250.52
250.53
250.60
250.61
250.62
250.63
250.70
250.71

Qualifying ICD-9 codes for participant selection
Code description
Type 2 or unspecified diabetes, not uncontrolled, without complication
Type 1 diabetes, not uncontrolled, without complication
Type 2 or unspecified diabetes, uncontrolled, without complication
Type 1 diabetes, uncontrolled, without complication
Type 2 or unspecified diabetes, not uncontrolled, with ketoacidosis
Type 1 diabetes, not uncontrolled, with ketoacidosis
Type 2 or unspecified diabetes, uncontrolled, with ketoacidosis
Type 1 diabetes, uncontrolled, with ketoacidosis
Type 2 or unspecified diabetes, not uncontrolled, with hyperosmolarity
Type 1 diabetes, not uncontrolled, with hyperosmolarity
Type 2 or unspecified diabetes, uncontrolled, with hyperosmolarity
Type 1 diabetes, uncontrolled, with hyperosmolarity
Type 2 or unspecified diabetes, not uncontrolled, with other coma
Type 1 diabetes, not uncontrolled, with other coma
Type 2 or unspecified diabetes, uncontrolled, with other coma
Type 1 diabetes, uncontrolled, with other coma
Type 2 or unspecified diabetes, not uncontrolled, with renal
manifestations
Type 1 diabetes, not uncontrolled, with renal manifestations
Type 2 or unspecified diabetes, uncontrolled, with renal manifestations
Type 1 diabetes, uncontrolled, with renal manifestations
Type 2 or unspecified diabetes, not uncontrolled, with ophthalmic
manifestations
Type 1 diabetes, not uncontrolled, with ophthalmic manifestations
Type 2 or unspecified diabetes, uncontrolled, with ophthalmic
manifestations
Type 1 diabetes, uncontrolled, with ophthalmic manifestations
Type 2 or unspecified diabetes, not uncontrolled, with neurological
manifestations
Type 1 diabetes, not uncontrolled, with neurological manifestations
Type 2 or unspecified diabetes, uncontrolled, with neurological
manifestations
Type 1 diabetes, uncontrolled, with neurological manifestations
Type 2 or unspecified diabetes, not uncontrolled, with peripheral
circulatory disorders
Type 1 diabetes, not uncontrolled, with peripheral circulatory disorders
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Table D-1.
ICD-9 code
250.72
250.73
250.80
250.81
250.82
250.83
250.90
250.91
250.92
250.93
357.2
250.72
250.73
250.80
250.81
250.82
250.83
250.90
250.91
250.92
250.93
357.2

(Continued)
Code description
Type 2 or unspecified diabetes, uncontrolled, with peripheral
circulatory disorders
Type 1 diabetes, uncontrolled, with peripheral circulatory disorders
Type 2 or unspecified diabetes, not uncontrolled, with other specified
manifestations
Type 1 diabetes, not uncontrolled, with other specified manifestations
Type 2 or unspecified diabetes, uncontrolled, with other specified
manifestations
Type 1 diabetes, uncontrolled, with other specified manifestations
Type 2 or unspecified diabetes, not uncontrolled, with unspecified
complication
Type 1 diabetes, not uncontrolled, with unspecified complication
Type 2 or unspecified diabetes, uncontrolled, with unspecified
complication
Type 1 diabetes, uncontrolled, with unspecified complication
Polyneuropathy in diabetes
Type 2 or unspecified diabetes, uncontrolled, with peripheral
circulatory disorders
Type 1 diabetes, uncontrolled, with peripheral circulatory disorders
Type 2 or unspecified diabetes, not uncontrolled, with other specified
manifestations
Type 1 diabetes, not uncontrolled, with other specified manifestations
Type 2 or unspecified diabetes, uncontrolled, with other specified
manifestations
Type 1 diabetes, uncontrolled, with other specified manifestations
Type 2 or unspecified diabetes, not uncontrolled, with unspecified
complication
Type 1 diabetes, not uncontrolled, with unspecified complication
Type 2 or unspecified diabetes, uncontrolled, with unspecified
complication
Type 1 diabetes, uncontrolled, with unspecified complication
Polyneuropathy in diabetes

Data Source: Centers for Disease Control and Prevention. International Classification of
Diseases, 9th revision, clinical modification (6 Nov 2015).
https://www.cdc.gov/nchs/icd/icd9cm.htm (accessed 11 Dec 2015).
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Table D-2.
ICD-10 code
E10.10
E10.11
E10.21
E10.22
E10.29
E10.311
E10.319
E10.321
E10.329
E10.331
E10.339
E10.341
E10.349
E10.351
E10.359
E10.36
E10.39
E10.40
E10.41
E10.42
E10.43
E10.44
E10.49
E10.51
E10.52
E10.59
E10.610
E10.618
E10.620
E10.621

Qualifying ICD-10 codes for participant selection
Code description
Type 1 diabetes with ketoacidosis, no coma
Type 1 diabetes with ketoacidosis with coma
Type 1 diabetes with diabetic nephropathy
Type 1 diabetes with diabetic chronic kidney disease
Type 1 diabetes with other diabetic kidney complication
Type 1 diabetes with unspecified diabetic retinopathy with macular
edema
Type 1 diabetes with unspecified diabetic retinopathy, no macular
edema
Type 1 diabetes with mild nonproliferative diabetic retinopathy with
macular edema
Type 1 diabetes with mild nonproliferative diabetic retinopathy, no
macular edema
Type 1 diabetes with moderate nonproliferative diabetic retinopathy
with macular edema
Type 1 diabetes with moderate nonproliferative diabetic retinopathy,
no macular edema
Type 1 diabetes with severe nonproliferative diabetic retinopathy with
macular edema
Type 1 diabetes with severe nonproliferative diabetic retinopathy, no
macular edema
Type 1 diabetes with proliferative diabetic retinopathy with macular
edema
Type 1 diabetes with proliferative diabetic retinopathy, no macular
edema
Type 1 diabetes with diabetic cataract
Type 1 diabetes with other diabetic ophthalmic complication
Type 1 diabetes with diabetic neuropathy, unspecified
Type 1 diabetes with diabetic mononeuropathy
Type 1 diabetes with diabetic polyneuropathy
Type 1 diabetes with diabetic autonomic (poly)neuropathy
Type 1 diabetes with diabetic amyotrophy
Type 1 diabetes with other diabetic neurological complication
Type 1 diabetes with diabetic peripheral angiopathy, no gangrene
Type 1 diabetes with diabetic peripheral angiopathy with gangrene
Type 1 diabetes with other circulatory complications
Type 1 diabetes with diabetic neuropathic arthropathy
Type 1 diabetes with other diabetic arthropathy
Type 1 diabetes with diabetic dermatitis
Type 1 diabetes with foot ulcer
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Table D-2.
ICD-10 code
E10.622
E10.628
E10.630
E10.638
E10.641
E10.649
E10.65
E10.69
E10.8
E10.9
E11.00
E11.01
E11.21
E11.22
E11.29
E11.311
E11.319
E11.321
E11.329
E11.331
E11.339
E11.341
E11.349
E11.351
E11.359
E11.36
E11.39
E11.40
E11.41
E11.42

(Continued)
Code description
Type 1 diabetes with other skin ulcer
Type 1 diabetes with other skin complications
Type 1 diabetes with periodontal disease
Type 1 diabetes with other oral complications
Type 1 diabetes with hypoglycemia with coma
Type 1 diabetes with hypoglycemia, no coma
Type 1 diabetes with hyperglycemia
Type 1 diabetes with other specified complication
Type 1 diabetes with unspecified complications
Type 1 diabetes without complications
Type 2 diabetes with hyperosmolarity, no nonketotic hyperglycemichyperosmolar coma
Type 2 diabetes with hyperosmolarity with coma
Type 2 diabetes with diabetic nephropathy
Type 2 diabetes with diabetic chronic kidney disease
Type 2 diabetes with other diabetic kidney complication
Type 2 diabetes with unspecified diabetic retinopathy with macular
edema
Type 2 diabetes with unspecified diabetic retinopathy, no macular
edema
Type 2 diabetes with mild nonproliferative diabetic retinopathy with
macular edema
Type 2 diabetes with mild nonproliferative diabetic retinopathy, no
macular edema
Type 2 diabetes with moderate nonproliferative diabetic retinopathy
with macular edema
Type 2 diabetes with moderate nonproliferative diabetic retinopathy,
no macular edema
Type 2 diabetes with severe nonproliferative diabetic retinopathy with
macular edema
Type 2 diabetes with severe nonproliferative diabetic retinopathy, no
macular edema
Type 2 diabetes with proliferative diabetic retinopathy with macular
edema
Type 2 diabetes with proliferative diabetic retinopathy without
macular edema
Type 2 diabetes with diabetic cataract
Type 2 diabetes with other diabetic ophthalmic complication
Type 2 diabetes with diabetic neuropathy, unspecified
Type 2 diabetes with diabetic mononeuropathy
Type 2 diabetes with diabetic polyneuropathy
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Table D-2.
ICD-10 code
E11.43
E11.44
E11.49
E11.51
E11.52
E11.59
E11.610
E11.618
E11.620
E11.621
E11.622
E11.628
E11.630
E11.638
E11.641
E11.649
E11.65
E11.69
E11.8
E11.9

(Continued)
Code description
Type 2 diabetes with diabetic autonomic (poly)neuropathy
Type 2 diabetes with diabetic amyotrophy
Type 2 diabetes with other diabetic neurological complication
Type 2 diabetes with diabetic peripheral angiopathy, no gangrene
Type 2 diabetes with diabetic peripheral angiopathy with gangrene
Type 2 diabetes with other circulatory complications
Type 2 diabetes with diabetic neuropathic arthropathy
Type 2 diabetes with other diabetic arthropathy
Type 2 diabetes with diabetic dermatitis
Type 2 diabetes with foot ulcer
Type 2 diabetes with other skin ulcer
Type 2 diabetes with other skin complications
Type 2 diabetes with periodontal disease
Type 2 diabetes with other oral complications
Type 2 diabetes with hypoglycemia with coma
Type 2 diabetes with hypoglycemia, no coma
Type 2 diabetes with hyperglycemia
Type 2 diabetes with other specified complication
Type 2 diabetes with unspecified complications
Type 2 diabetes without complications

Data Source: Centers for Disease Control and Prevention. International Classification of
Diseases, 10th revision, clinical modification (6 Nov 2015).
https://www.cdc.gov/nchs/icd/icd10cm.htm (accessed 11 Dec 2015).

76

VITA

Jieyu Luo, born 1988, is from Memphis, TN. In 2010, she enrolled in the
PharmD/PhD dual degree program at the University of Tennessee Health Science Center.
She earned her Doctor of Pharmacy degree in 2014. She anticipates completing the
requirements for her Doctor of Philosophy degree in Health Policy and Outcomes
Research in 2021. Her research interests include health and healthcare disparities,
mHealth, and public and community health.

77

